DENTSPLY SIRONA (XRAY) 10-Q 7 Aug 18 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Jul. 26, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	DENTSPLY SIRONA Inc.
Entity Central Index Key	818,479
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Trading Symbol	XRAY
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		222,344,874

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net sales	$ 1,042.1	$ 992.7	$ 1,998.2	$ 1,893.2
Cost of products sold	489.3	448.5	931.3	857
Gross profit	552.8	544.2	1,066.9	1,036.2
Selling, general and administrative expenses	432.2	417.6	867.4	822.3
Goodwill impairment	1,085.8	1,092.9	1,085.8	1,092.9
Restructuring and other costs	188.9	81.7	199.1	84.8
Operating loss	(1,154.1)	(1,048)	(1,085.4)	(963.8)
Other income and expenses:
Interest expense	9.6	9.6	18.2	18.9
Interest income	(0.4)	(0.6)	(1)	(1.3)
Other expense (income), net	(1)	7.8	(35.1)	6.8
Loss before income taxes	(1,162.3)	(1,064.8)	(1,067.5)	(988.2)
Provision (benefit) for income taxes	(41.3)	(14.5)	(27.6)	2.4
Net loss	(1,121)	(1,050.3)	(1,039.9)	(990.6)
Less: Net income (loss) attributable to noncontrolling interests	1	(0.3)	0.9	(0.4)
Net loss attributable to Dentsply Sirona	$ (1,122)	$ (1,050)	$ (1,040.8)	$ (990.2)
Net loss per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (4.98)	$ (4.58)	$ (4.60)	$ (4.31)
Diluted (in dollars per share)	$ (4.98)	$ (4.58)	$ (4.60)	$ (4.31)
Weighted average common shares outstanding:
Basic (in shares)	225.2	229.4	226.2	229.7
Diluted (in shares)	225.2	229.4	226.2	229.7
Dividends declared per common share (in dollars per share)	$ 0.0875	$ 0.0875	$ 0.1750	$ 0.1750

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Statement of Comprehensive Income [Abstract]
Net loss	$ (1,121)	$ (1,050.3)	$ (1,039.9)	$ (990.6)
Other comprehensive (loss) income, net of tax:
Foreign currency translation (loss) gain	(192.6)	222	(126.9)	271.7
Net gain (loss) on derivative financial instruments	29.6	(2.5)	17.6	(5.8)
Net realized holding gain on available for sale securities	0	0	(44.3)	0
Pension liability gain	3	1.1	4.2	2.3
Total other comprehensive (loss) income, net of tax	(160)	220.6	(149.4)	268.2
Total comprehensive loss	(1,281)	(829.7)	(1,189.3)	(722.4)
Less: Comprehensive income attributable to noncontrolling interests	0.8	0.3	1.3	0.1
Comprehensive loss attributable to Dentsply Sirona	$ (1,281.8)	$ (830)	$ (1,190.6)	$ (722.5)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 239.3	$ 320.6
Accounts and notes receivables-trade, net	710.3	746.2
Inventories, net	666.3	623.1
Prepaid expenses and other current assets, net	276.5	312.6
Total Current Assets	1,892.4	2,002.5
Property, plant and equipment, net	857.6	876
Identifiable intangible assets, net	2,546.8	2,800.7
Goodwill, net	3,457.8	4,539.2
Other noncurrent assets, net	67.4	156.1
Total Assets	8,822	10,374.5
Current Liabilities:
Accounts payable	292.4	284.4
Accrued liabilities	575.3	585.8
Income taxes payable	31.9	54.2
Notes payable and current portion of long-term debt	218.1	30.1
Total Current Liabilities	1,117.7	954.5
Long-term debt	1,586.6	1,611.6
Deferred income taxes	538	718
Other noncurrent liabilities	439.6	462.5
Total Liabilities	3,681.9	3,746.6
Commitments and contingencies	0	0
Equity:
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued	0	0
Common stock, $.01 par value; 400.0 million shares authorized and 264.5 million shares issued at June 30, 2018 and December 31, 2017, respectively; 222.2 million and 226.8 million shares outstanding at June 30, 2018 and December 31, 2017, respectively	2.6	2.6
Capital in excess of par value	6,526.2	6,543.9
Retained earnings	1,216.2	2,316.2
Accumulated other comprehensive loss	(440.8)	(291)
Treasury stock, at cost, 42.3 million and 37.7 million shares at June 30, 2018 and December 31, 2017, respectively	(2,177)	(1,955.4)
Total Dentsply Sirona Equity	5,127.2	6,616.3
Noncontrolling interests	12.9	11.6
Total Equity	5,140.1	6,627.9
Total Liabilities and Equity	$ 8,822	$ 10,374.5

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	250,000	250,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	264,500,000	264,500,000
Common stock, shares outstanding (in shares)	222,200,000	226,800,000
Treasury stock, shares (in shares)	42,300,000	37,700,000

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Total Dentsply Sirona Equity	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect on adoption of new accounting pronouncement	$ (0.5)	$ (0.5)		$ 1	$ (1.5)
Beginning Balance at Dec. 31, 2016	8,125.9	8,114.3	$ 2.6	6,516.7	3,948	$ (705.7)	$ (1,647.3)	$ 11.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(990.6)	(990.2)			(990.2)			(0.4)
Other comprehensive (loss) income	268.2	267.7				267.7		0.5
Exercise of stock options	45.4	45.4		6.3			39.1
Stock based compensation expense	21.9	21.9		21.9
Funding of Employee Stock Ownership Plan	6.6	6.6		3.3			3.3
Treasury shares purchased	(150.3)	(150.3)					(150.3)
RSU distributions	(12)	(12)		(22.1)			10.1
RSU dividends	0			0.3	(0.3)
Cash dividends	(40.4)	(40.4)			(40.4)
Ending Balance at Jun. 30, 2017	7,274.2	7,262.5	2.6	6,527.4	2,915.6	(438)	(1,745.1)	11.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect on adoption of new accounting pronouncement | ASU 2014-09	(6)	(6)			(6)
Cumulative effect on adoption of new accounting pronouncement | ASU 2016-16	(2.7)	(2.7)			(2.7)
Cumulative effect on adoption of new accounting pronouncement | ASU 2018-02	8.1	8.1			8.1
Beginning Balance at Dec. 31, 2017	6,627.9	6,616.3	2.6	6,543.9	2,316.2	(291)	(1,955.4)	11.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1,039.9)	(1,040.8)			(1,040.8)			0.9
Other comprehensive (loss) income	(149.4)	(149.8)				(149.8)		0.4
Exercise of stock options	11.2	11.2		(6.4)			17.6
Stock based compensation expense	9.8	9.8		9.8
Treasury shares purchased	(250.2)	(250.2)					(250.2)
RSU distributions	(10.4)	(10.4)		(21.4)			11
RSU dividends	0			0.3	(0.3)
Cash dividends	(58.3)	(58.3)			(58.3)
Ending Balance at Jun. 30, 2018	$ 5,140.1	$ 5,127.2	$ 2.6	$ 6,526.2	$ 1,216.2	$ (440.8)	$ (2,177)	$ 12.9

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss	$ (1,039.9)	$ (990.6)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	68.8	62.1
Amortization of intangible assets	100.1	91.8
Amortization of deferred financing costs	1.3	1.3
Goodwill impairment	1,085.8	1,092.9
Indefinite-lived intangible asset impairment	179.2	79.8
Deferred income taxes	(70.8)	(34.2)
Stock based compensation expense	9.8	21.9
Restructuring and other costs - non-cash	9.1	1
Other non-cash (income) expense	(2.9)	5.5
Loss on disposal of property, plant and equipment	0.6	0.4
Gain on sale of equity security	(44.1)	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	23	1.9
Inventories, net	(69.3)	(49.6)
Prepaid expenses and other current assets, net	(25.7)	(59.3)
Other noncurrent assets, net	(7.7)	1.2
Accounts payable	(6.5)	9.5
Accrued liabilities	(4.6)	(19.2)
Income taxes	(28.5)	(15.4)
Other noncurrent liabilities	(5.7)	7.7
Net cash provided by operating activities	172	208.7
Cash flows from investing activities:
Capital expenditures	(81.2)	(64.8)
Cash paid for acquisitions of businesses and equity investments, net of cash acquired	(130.5)	(125.2)
Cash received on derivatives contracts	1.9	5.3
Cash paid on derivatives contracts	(2.4)	0
Expenditures for identifiable intangible assets	(5.3)	(5.9)
Purchase of short-term investments	0	(2.3)
Purchase of Company-owned life insurance policies	0	(0.9)
Proceeds from sale of equity security	54.1	0
Proceeds from sale of property, plant and equipment, net	3.9	1.9
Net cash used in investing activities	(159.5)	(191.9)
Cash flows from financing activities:
Increase in short-term borrowings	187.3	1.4
Cash paid for treasury stock	(250.2)	(151.5)
Cash dividends paid	(39.7)	(38.1)
Proceeds from long-term borrowings	0.3	2.9
Repayments on long-term borrowings	(0.4)	(6.6)
Proceeds from exercised stock options	13.9	45.4
Net cash used in financing activities	(88.8)	(146.5)
Effect of exchange rate changes on cash and cash equivalents	(5)	14.2
Net decrease in cash and cash equivalents	(81.3)	(115.5)
Cash and cash equivalents at beginning of period	320.6	383.9
Cash and cash equivalents at end of period	$ 239.3	$ 268.4

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules of the U.S. Securities and Exchange Commission (“SEC”). The year-end consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by US GAAP. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These financial statements and related notes contain the accounts of DENTSPLY SIRONA Inc. and Subsidiaries (“Dentsply Sirona” or the “Company”) on a consolidated basis and should be read in conjunction with the consolidated financial statements and notes included in the Company’s most recent Form 10-K for the year ended December 31, 2017 . The accounting policies of the Company, as applied in the interim consolidated financial statements presented herein are substantially the same as presented in the Company’s Form 10-K for the year ended December 31, 2017 , except as may be indicated below. Revenue Recognition Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of risk and/or control of Dental and Healthcare Consumables products (“consumable” products), Dental Technology products (“technology” products), or Dental Equipment products (“equipment” products). Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Sales, value add and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. For most of consumable, technology and equipment products, the Company transfers control and recognizes a sale when products are shipped from the manufacturing facility or warehouse to the customer (distributors and direct to dentists). For contracts with customers that contain destination shipping terms, revenue is not recognized until risk has transferred and the goods are delivered to the agreed upon destination. The amount of consideration received and revenue recognized varies with changes in marketing incentives (e.g., discounts, rebates, free goods) and returns offered to customers and their customers. When the Company gives customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty related returns, are infrequent and insignificant. The Company adjusts the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Depending on the terms of the arrangement, the Company will defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied (e.g., extended maintenance/service contracts, software and licenses, customer loyalty points and coupon programs). The Company uses an observable price, typically average selling price, to determine the stand-alone selling price for separate performance obligations. The Company determines the stand-alone selling price, based on Company geographic sales locations’ database of pricing and discounting practices for the specific product or service when sold separately, and utilizes this data to arrive at average selling prices by product. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to the unsatisfied performance obligation, which is deferred until satisfied. At June 30, 2018, the Company had $26.2 million of deferred revenue recorded in Accrued liabilities on the Consolidated Balance Sheets. The Company expects to recognize significantly all of the deferred revenue within the next twelve months. The Company has elected to account for shipping and handling activities as a fulfillment cost within the cost of products sold, and records shipping and handling costs collected from customers in net sales. The Company has adopted two practical expedients: the “right to invoice” practical expedient, which allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date; and relief from considering the existence of a significant financing component when the payment for the good or service is expected to be one year or less. The Company offers discounts to its customers and distributors if certain conditions are met. Discounts are primarily based on the volume of products purchased or targeted to be purchased by the customer. Discounts are deducted from revenue at the time of sale or when the discount is offered, whichever is later. The Company estimates volume discounts based on an individual customer’s historical and estimated future product purchases. Certain of the Company’s customers are offered cash rebates based on targeted sales increases. The Company estimates rebates based on the forecasted performance of a customer and their expected level of achievement within the rebate programs. In accounting for these rebate programs, the Company records an accrual and reduces sales ratably as sales occur over the rebate period. The Company updates the accruals for these rebate programs as actual results and updated forecasts impact the estimated achievement for customers within the rebate programs. A portion of the Company’s net sales is comprised of sales of precious metals generated through its precious metal dental alloy product offerings. As the precious metal content of the Company’s sales is largely a pass-through to customers, the Company uses its cost of precious metal purchased as a proxy for the precious metal content of sales, as the precious metal content of sales is not separately tracked and invoiced to customers. The Company believes that it is reasonable to use the cost of precious metal content purchased in this manner since precious metal alloy sale prices are typically adjusted when the prices of underlying precious metals change. Accounts and Notes Receivable The Company records a provision for doubtful accounts, which is included in Selling, general and administrative expenses on the Consolidated Statements of Operations. Accounts and notes receivables – trade, net are stated net of allowances for doubtful accounts and trade discounts, which were $ 23.4 million at June 30, 2018 and $ 22.4 million at December 31, 2017 . Marketable Securities During the three months ended March 31, 2018, the Company sold its direct investment in the DIO Corporation (“DIO”) for $54.1 million , resulting in a gain of $44.1 million . At December 31, 2017, the Company had recorded an unrealized gain of $45.0 million in accumulated other comprehensive loss. This gain was transferred out of Accumulated other comprehensive loss (“AOCI”), and recorded in Other expense (income), net on the Consolidated Statements of Operations. The fair value of the direct investment at December 31, 2017 was $54.4 million . Income Taxes The Company has accounted for the tax effects of the Tax Cuts and Jobs Act, enacted on December 22, 2017, on a provisional basis. At December 31, 2017, the accounting for certain income tax effects was incomplete, but the Company determined reasonable estimates for those effects which were included in the financial statements. The Company expects to complete the accounting during 2018 in accordance with the one year measurement period. Recently Adopted Accounting Pronouncements Effective January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers”, as amended (Topic 606, commonly referred to as ASC 606) to all contracts using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Most of the Company’s sales revenue continues to be recognized when products are shipped from manufacturing facilities. For certain customer and dealer incentive programs, such as coupons, customer loyalty and free goods, the Company recognizes the proportionate revenue and cost of product when the incentives are shipped or awarded. Prior to adoption of ASC 606, costs for these types of programs were recognized when triggering events occurred. For contracts with customers where performance occurs over time, such as software sales, the Company recognizes revenue ratably over the performance period. The new revenue standard also provided additional guidance that resulted in reclassifications to or from Net sales, Cost of products sold, Selling, general and administrative expenses, and the resultant change in Provision (benefit) for income taxes. The cumulative effect of the changes made on the Consolidated Balance Sheets at December 31, 2017 for the adoption of ASC 606, is as follows: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASC 606 January 1, 2018 Revised Balance Assets Accounts and notes receivable-trade, net $ 746.2 $ 0.2 $ 746.4 Inventory, net 623.1 (0.3 ) 622.8 Prepaid expense and other current assets, net 312.6 1.9 314.5 Liabilities and Equity Accrued liabilities 585.8 9.9 595.7 Income taxes payable 54.2 (2.1 ) 52.1 Retained earnings 2,316.2 (6.0 ) 2,310.2 The impact of adopting the new revenue recognition standard on the Company’s Consolidated Statements of Operations and Consolidated Balance Sheets is as follows: (in millions) Three Months Ended June 30, 2018 Six Months Ended June 30, 2018 Consolidated Statements of Operations Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Net sales $ 1,042.1 $ 1,044.8 $ (2.7 ) $ 1,998.2 $ 1,998.8 $ (0.6 ) Cost of products sold 489.3 491.4 (2.1 ) 931.3 930.3 1.0 Selling, general and administrative expenses 432.2 432.3 (0.1 ) 867.4 868.1 (0.7 ) Provision (benefit) for income taxes (41.3 ) (41.2 ) (0.1 ) (27.6 ) (27.4 ) (0.2 ) Net loss attributable to Dentsply Sirona (1,122.0 ) (1,121.6 ) (0.4 ) (1,040.8 ) (1,040.1 ) (0.7 ) (in millions) Balance at June 30, 2018 Consolidated Balance Sheets Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Assets Accounts and notes receivables-trade, net $ 710.3 $ 710.2 $ 0.1 Inventories, net 666.3 666.6 (0.3 ) Prepaid expenses and other current assets, net 276.5 273.4 3.1 Liabilities and Equity Accrued liabilities 575.3 563.4 11.9 Income taxes payable 31.9 34.2 (2.3 ) Retained earnings 1,216.2 1,222.9 (6.7 ) Effective January 1, 2018, the Company adopted ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” This accounting standard seeks to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Previously, US GAAP prohibited the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to a third party, which is an exception to the principle of comprehensive recognition of current and deferred income taxes in US GAAP. ASU No. 2016-16 eliminates this exception. The Company adopted this accounting standard using the modified retrospective method with a cumulative-effect adjustment directly to retained earnings. Upon adoption, the Company made the following reclassification: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASU 2016-16 Increase/(Decrease) January 1, 2018 Revised Balance Assets Prepaid expenses and other current assets, net $ 312.6 $ (5.6 ) $ 307.0 Other noncurrent assets, net 156.1 (73.1 ) 83.0 Liabilities and Equity Deferred income taxes 718.0 (76.0 ) 642.0 Retained earnings 2,316.2 (2.7 ) 2,313.5 In March 2017, the FASB issued ASU No. 2017-07, “Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.” This newly issued accounting standard is primarily intended to improve the presentation of net periodic pension cost and net periodic postretirement benefit cost. The amendments in this update require an employer to report the service cost component of net periodic benefit cost in operating income, while the interest cost, amortization, return on assets and any settlement or curtailment expense will be reported below operating income. More specifically, the service cost will be reported in the same line item as other compensation costs arising from the services rendered by the pertinent employee during the period. The amendments in this update are required for annual and interim periods beginning after December 15, 2017, and should be applied retrospectively for the presentation of the components of net periodic benefit cost and net periodic postretirement benefit cost in the income statement. The amendment allows a practical expedient that permits an employer to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. The Company adopted this accounting standard on January 1, 2018, and applied the practical expedient upon adoption. The impact of adopting this standard, by financial statement line item, is reflected below: (in millions) Consolidated Statements of Operations Item Three Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Three Months Ended June 30, 2017 Revised Cost of products sold $ 448.5 $ (0.3 ) $ 448.2 Gross profit 544.2 0.3 544.5 Selling, general and administrative expense 417.6 (1.9 ) 415.7 Operating loss (1,048.0 ) 2.2 (1,045.8 ) Other expense (income), net 7.8 2.2 10.0 (in millions) Consolidated Statements of Operations Item Six Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Six Months Ended June 30, 2017 Revised Cost of products sold $ 857.0 $ (0.8 ) $ 856.2 Gross profit 1,036.2 0.8 1,037.0 Selling, general and administrative expense 822.3 (3.6 ) 818.7 Operating loss (963.8 ) 4.4 (959.4 ) Other expense (income), net 6.8 4.4 11.2 In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This newly issued accounting standard allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from tax rate changes due to the Tax Cuts and Jobs Act. The amendments in this update are required for annual and interim periods beginning after December 15, 2018. This standard also requires the Company to disclose its accounting policy for releasing income tax effects from accumulated other comprehensive income. In general, the Company applies the individual item approach. As permitted by the accounting standard, the Company early adopted this accounting standard on January 1, 2018. As a result of the adoption, the Company elected to reclassify the income tax effects from AOCI to Retained earnings and reclassified $8.1 million . Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) with subsequent amendments (collectively, “Topic 842”). This accounting standard seeks to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The adoption of this standard is required for interim and fiscal periods ending after December 15, 2018, using the modified retrospective approach. Topic 842 provides for an additional optional transition method that allows application of the new standard beginning January 1, 2019 with recognition of a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Periods prior to adoption would continue to conform to current US GAAP (Topic 840, Leases) and periods after adoptions would conform to Topic 842. The Company anticipates adopting Topic 842 using the optional transition method and is currently assessing the impact that this standard will have on its financial position, results of operations, cash flows and disclosures. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.” This newly issued accounting standard improves the financial reporting and disclosure of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. The amendments in this update make improvements to simplify the application of the hedge accounting guidance in current US GAAP based on the feedback received from preparers, auditors, users and other stakeholders. More specifically, this update expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. The amendments in this update are required for annual and interim periods beginning after December 15, 2018. Early adoption is permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. For cash flow and net investment hedges existing at the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the amendments in this update. The amended presentation and disclosure guidance is required only prospectively. The Company is currently assessing the impact that this standard will have on its financial position, results of operations, cash flows and disclosures.

STOCK COMPENSATION

STOCK COMPENSATION	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK COMPENSATION	STOCK COMPENSATION The following table represents total stock based compensation expense for non-qualified stock options, restricted stock units (“RSU”) and the tax related benefit for the three and six months ended June 30, 2018 and 2017 . Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Stock option expense $ 2.7 $ 2.5 $ 3.4 $ 5.2 RSU expense (2.6 ) 8.0 5.9 15.7 Total stock based compensation expense $ 0.1 $ 10.5 $ 9.3 $ 20.9 Related deferred income tax benefit $ — $ 2.5 $ 1.6 $ 5.8 For the three and six months ended June 30, 2018 , stock compensation expense of $0.1 million and $ 9.3 million , respectively, was recorded on the Consolidated Statements of Operations. For the three months ended June 30, 2018 the Company lowered the likely payout level on certain performance-based grants. For the three and six months ended June 30, 2018 , $1.2 million and $ 8.3 million , respectively, was recorded in Selling, general, and administrative expense, and $0.1 million and $ 0.4 million , respectively, was recorded in Cost of products sold on the Consolidated Statements of Operations. For the three and six months ended June 30, 2018 , the Company recorded income of $ 1.2 million and expense of $ 0.5 million , respectively, in Restructuring and other costs on the Consolidated Statements of Operations. For the three and six months ended June 30, 2017 , stock compensation expense of $10.5 million and $ 20.9 million , respectively, was recorded on the Consolidated Statements of Operations. For the three and six months ended June 30, 2017 , $10.3 million and $ 20.4 million , respectively, was recorded in Selling, general, and administrative expense, and $0.2 million and $ 0.5 million , respectively, was recorded in Cost of products sold on the Consolidated Statements of Operations.

COMPREHENSIVE INCOME (LOSS)

COMPREHENSIVE INCOME (LOSS)	6 Months Ended
	Jun. 30, 2018
COMPREHENSIVE INCOME [Abstract]
COMPREHENSIVE INCOME (LOSS)	COMPREHENSIVE INCOME (LOSS) The following table summarizes the components of comprehensive income (loss), net of tax, for the three and six months ended June 30, 2018 and 2017 : Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Foreign currency translation gains $ — $ 248.2 $ — $ 304.8 Foreign currency translation losses (223.4 ) — (139.4 ) — Foreign currency translation gain on hedges of net investments 31.0 — 12.1 — Foreign currency translation loss on hedges of net investments — (24.2 ) — (33.6 ) These amounts are recorded in AOCI, net of any related tax adjustments. At June 30, 2018 and December 31, 2017 , the cumulative tax adjustments were $ 168.5 million and $ 203.8 million , respectively, primarily related to foreign currency translation gains and losses. The cumulative foreign currency translation adjustments included translation losses of $117.3 million and gains $22.1 million at June 30, 2018 and December 31, 2017 , respectively, and cumulative losses on loans designated as hedges of net investments of $114.5 million and $126.6 million , respectively. These foreign currency translation gains and losses were partially offset by movements on derivative financial instruments, which are discussed in Note 10 , Financial Instruments and Derivatives. Changes in AOCI, net of tax, by component for the six months ended June 30, 2018 and 2017 were as follows: (in millions) Foreign Currency Translation Gain (Loss) Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities Pension Liability Gain (Loss) Total Balance, net of tax, at December 31, 2017 $ (104.5 ) $ (12.6 ) $ (127.6 ) $ 44.3 $ (90.6 ) $ (291.0 ) Other comprehensive (loss) income before reclassifications and tax impact (106.6 ) (4.2 ) 29.4 — 2.4 (79.0 ) Tax (expense) benefit (20.7 ) 0.5 (14.5 ) (0.6 ) (35.3 ) Other comprehensive (loss) income, net of tax, before reclassifications (127.3 ) (3.7 ) 14.9 — 1.8 (114.3 ) Amounts reclassified from accumulated other comprehensive income (loss), net of tax — 6.4 — (44.3 ) 2.4 (35.5 ) Net (decrease) increase in other comprehensive income (127.3 ) 2.7 14.9 (44.3 ) 4.2 (149.8 ) Balance, net of tax, at June 30, 2018 $ (231.8 ) $ (9.9 ) $ (112.7 ) $ — $ (86.4 ) $ (440.8 ) (in millions) Foreign Currency Translation Gain (Loss) Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Pension Liability Gain (Loss) Total Balance, net of tax, at December 31, 2016 $ (490.5 ) $ (3.2 ) $ (116.8 ) $ (95.2 ) $ (705.7 ) Other comprehensive income (loss) before reclassifications and tax impact 245.8 (2.7 ) (4.2 ) — 238.9 Tax benefit 25.4 0.2 0.8 — 26.4 Other comprehensive income (loss), net of tax, before reclassifications 271.2 (2.5 ) (3.4 ) — 265.3 Amounts reclassified from accumulated other comprehensive income, net of tax — 0.1 — 2.3 2.4 Net increase (decrease) in other comprehensive income 271.2 (2.4 ) (3.4 ) 2.3 267.7 Balance, net of tax, at June 30, 2017 $ (219.3 ) $ (5.6 ) $ (120.2 ) $ (92.9 ) $ (438.0 ) Reclassifications out of AOCI to the Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 were as follows: (in millions) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item on the Consolidated Statements of Operations Three Months Ended 2018 2017 (Loss) gain on derivative financial instruments: Interest rate swaps $ (0.5 ) $ (0.4 ) Interest expense Foreign exchange forward contracts (4.3 ) 0.5 Cost of products sold Net (loss) gain before tax (4.8 ) 0.1 Tax impact 0.7 — Provision (benefit) for income taxes Net (loss) gain after tax $ (4.1 ) $ 0.1 Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ — $ 0.1 (a) Amortization of net actuarial losses (1.7 ) (1.7 ) (a) Net loss before tax (1.7 ) (1.6 ) Tax impact 0.5 0.5 Provision (benefit) for income taxes Net loss after tax $ (1.2 ) $ (1.1 ) Total reclassifications for the period $ (5.3 ) $ (1.0 ) (a) These AOCI components are included in the computation of net periodic benefit cost for the three months ended June 30, 2018 and 2017 (see Note 8 , Benefit Plans, for additional details). (in millions) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item on the Consolidated Statements of Operations Six Months Ended 2018 2017 Loss on derivative financial instruments: Interest rate swaps $ (1.1 ) $ (1.1 ) Interest expense Foreign exchange forward contracts (6.1 ) 1.0 Cost of products sold Net loss before tax (7.2 ) (0.1 ) Tax impact 0.8 — Provision (benefit) for income taxes Net loss after tax $ (6.4 ) $ (0.1 ) Net realized holding gain on available-for-sale securities: Available-for-sale securities $ 45.0 $ — Other expense (income), net Tax impact (0.7 ) — Provision (benefit) for income taxes Net gain after tax $ 44.3 $ — Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ — $ 0.1 (a) Amortization of net actuarial losses (3.4 ) (3.4 ) (a) Net loss before tax (3.4 ) (3.3 ) Tax impact 1.0 1.0 Provision (benefit) for income taxes Net loss after tax $ (2.4 ) $ (2.3 ) Total reclassifications for the period $ 35.5 $ (2.4 ) (a) These AOCI components are included in the computation of net periodic benefit cost for the six months ended June 30, 2018 and 2017 (see Note 8 , Benefit Plans, for additional details).

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	6 Months Ended
	Jun. 30, 2018
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The calculation of weighted average diluted common shares outstanding excludes stock options and RSUs of 5.5 million and 4.7 million equivalent shares of common stock that were outstanding during the three and six months ended June 30, 2018 , respectively, because their effect would be antidilutive. There were 0.8 million and 1.2 million antidilutive equivalent shares of common stock outstanding during the three and six months ended June 30, 2017 , respectively.

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	6 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS On May 1, 2018 , the Company acquired all of the outstanding shares of privately held OraMetrix, Inc. for $120.0 million , with an additional payment totaling $30.0 million , subject to meeting earn-out provisions. OraMetrix specializes in orthodontic treatment planning software, wire bending, and clear aligner manufacturing and is headquartered in Richardson, Texas. At June 30, 2018, the Company recorded a preliminary estimate of $62.8 million in goodwill related to the fair value of assets acquired and liabilities assumed and the consideration given for the acquisition. The purchase price has been assigned on the basis of the preliminary estimate of the fair values of assets acquired and liabilities assumed. Goodwill is considered to represent the value associated with workforce and synergies the two companies anticipate realizing as a combined company. The goodwill is not expected to be deductible for tax purposes. Intangible assets acquired consist of the following: Weighted Average Useful Life (in millions, except for useful life) Amount (in years) Customer relationships $ 17.5 15 Developed technology and patents 63.4 15 Trade names and trademarks 12.8 Indefinite Total $ 93.7 During the quarter ended June 30, 2017, the Company acquired Recherche Techniques Dentaires (“RTD”), a privately-held France-based manufacturer of endodontic posts for $ 132.0 million . The Company recorded $ 83.9 million in goodwill related to the fair value of assets acquired and liabilities assumed and the consideration given for the acquisition. Goodwill is considered to represent the value associated with workforce and synergies the two companies anticipate realizing as a combined company. The goodwill is not expected to be deductible for tax purposes. Intangible assets acquired consist of the following: Weighted Average Useful Life (in millions, except for useful life) Amount (in years) Customer relationships $ 18.1 15 Developed technology and patents 22.4 15 Trade names and trademarks 8.5 Indefinite Total $ 49.0 The results of operations for these businesses have been included in the accompanying financial statements as of the effective date of each transactions. These transactions were not material to the Company’s net sales and net loss attributable to Dentsply Sirona for the quarter ended June 30, 2018 .

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company has numerous operating businesses covering a wide range of dental consumable products and dental technology products primarily serving the professional dental market, and certain healthcare products. Professional dental products represented approximately 92% of net sales for all periods presented. The operating businesses are combined into two operating groups, which generally have overlapping geographical presence, customer bases, distribution channels, and regulatory oversight. These operating groups are considered the Company’s reportable segments as the Company’s chief operating decision-maker regularly reviews financial results at the operating group level and uses this information to manage the Company’s operations. The accounting policies of the segments are consistent with those described in the Company’s most recently filed Form 10-K, in the summary of significant accounting policies. The Company evaluates performance of the segments based on the groups’ net third party sales, excluding precious metal content, and segment adjusted operating income. The Company defines net third party sales excluding precious metal content as the Company’s net sales excluding the precious metal cost within the products sold, which is considered a measure not calculated in accordance with US GAAP, and is therefore considered a non-US GAAP measure. Management believes that the presentation of net sales, excluding precious metal content, provides useful information to investors because a portion of Dentsply Sirona’s net sales is comprised of sales of precious metals generated through sales of the Company’s precious metal dental alloy products, which are used by third parties to construct crown and bridge materials. Due to the fluctuations of precious metal prices and because the cost of the precious metal content of the Company’s sales is largely passed through to customers and has minimal effect on earnings, Dentsply Sirona reports net sales both with and without precious metal content to show the Company’s performance independent of precious metal price volatility and to enhance comparability of performance between periods. The Company uses its cost of precious metal purchased as a proxy for the precious metal content of sales, as the precious metal content of sales is not separately tracked and invoiced to customers. The Company believes that it is reasonable to use the cost of precious metal content purchased in this manner since precious metal dental alloy sale prices are typically adjusted when the prices of underlying precious metals change. The Company’s exclusion of precious metal content in the measurement of net third party sales enhances comparability of performance between periods as it excludes the fluctuating market prices of the precious metal content. The Company also evaluates segment performance based on each segment’s adjusted operating income before provision for income taxes and interest. Segment adjusted operating income is defined as operating income before income taxes and before certain corporate headquarter unallocated costs, restructuring and other costs, interest expense, interest income, other expense (income), net, amortization of intangible assets and depreciation resulting from the fair value step-up of property, plant and equipment from acquisitions. The Company’s segment adjusted operating income is considered a non-US GAAP measure. A description of the products and services provided within each of the Company’s two operating segments is provided below. Technologies & Equipment This segment is responsible for the worldwide design, manufacture, sales and distribution of the Company’s Dental Technology and Equipment Products and Healthcare Consumable Products. These products include dental implants, laboratory dental products, CAD/CAM systems, imaging systems, treatment centers, as well as consumable medical device products. Consumables This segment is responsible for the worldwide design, manufacture, sales and distribution of the Company’s Dental Consumable Products which include preventive, restorative, instruments, endodontic, and orthodontic dental products. The following tables set forth information about the Company’s segments for the three and six months ended June 30, 2018 and 2017 . Certain reclassifications have been made to the prior year’s data in order to conform to the current year presentation: Third Party Net Sales Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 548.8 $ 532.8 $ 1,057.1 $ 1,011.8 Consumables 493.3 459.9 941.1 881.4 Total net sales $ 1,042.1 $ 992.7 $ 1,998.2 $ 1,893.2 Third Party Net Sales, Excluding Precious Metal Content Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 539.4 $ 523.1 $ 1,037.4 $ 991.0 Consumables 493.3 459.9 941.1 881.4 Total net sales, excluding precious metal content 1,032.7 983.0 1,978.5 1,872.4 Precious metal content of sales 9.4 9.7 19.7 20.8 Total net sales, including precious metal content $ 1,042.1 $ 992.7 $ 1,998.2 $ 1,893.2 Segment Adjusted Operating Income Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 77.1 $ 98.0 $ 151.8 $ 151.9 Consumables 146.0 122.8 253.2 238.9 Segment adjusted operating income before income taxes and interest 223.1 220.8 405.0 390.8 Reconciling items expense (income): All Other (a) 50.5 46.3 101.8 82.3 Goodwill impairment 1,085.8 1,092.9 1,085.8 1,092.9 Restructuring and other costs 188.9 81.7 199.1 84.8 Interest expense 9.6 9.6 18.2 18.9 Interest income (0.4 ) (0.6 ) (1.0 ) (1.3 ) Other expense (income), net (1.0 ) 7.8 (35.1 ) 6.8 Amortization of intangible assets 50.2 46.5 100.1 91.8 Depreciation resulting from the fair value step-up of property, plant and equipment from business combinations 1.8 1.4 3.6 2.8 Loss before income taxes $ (1,162.3 ) $ (1,064.8 ) $ (1,067.5 ) $ (988.2 ) (a) Includes the results of unassigned Corporate headquarter costs, inter-segment eliminations and one distribution warehouse not managed by named segments.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2018
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost and net realizable value. The cost of inventories determined by the last-in, first-out (“LIFO”) method at June 30, 2018 and December 31, 2017 were $ 12.7 million and $ 12.4 million , respectively. The cost of remaining inventories was determined by the first-in, first-out (“FIFO”) or average cost methods. If the FIFO method had been used to determine the cost of LIFO inventories, the amounts at which net inventories are stated would be higher than reported at June 30, 2018 and December 31, 2017 by $ 8.8 million and $ 10.6 million , respectively. Inventories, net of inventory valuation reserves, consist of the following: (in millions) June 30, 2018 December 31, 2017 Finished goods $ 441.6 $ 387.6 Work-in-process 88.4 90.4 Raw materials and supplies 136.3 145.1 Inventories, net $ 666.3 $ 623.1 The inventory valuation allowance was $ 75.1 million and $ 71.7 million at June 30, 2018 and December 31, 2017 , respectively.

BENEFIT PLANS

BENEFIT PLANS	6 Months Ended
	Jun. 30, 2018
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
BENEFIT PLANS	BENEFIT PLANS The following sets forth the components of net periodic benefit cost of the Company’s defined benefit plans for the three and six months ended June 30, 2018 and 2017 : Defined Benefit Plans Three Months Ended Six Months Ended Location on Consolidated Statements of Operations (in millions) 2018 2017 (a) 2018 2017 (a) Service cost $ 1.9 $ 2.0 $ 3.7 $ 3.7 Cost of products sold Service cost 2.1 1.9 4.5 4.0 Selling, general and administrative expenses Interest cost 1.9 1.8 3.6 3.5 Other expense (income), net Expected return on plan assets (1.3 ) (1.2 ) (2.7 ) (2.3 ) Other expense (income), net Amortization of prior service credit (0.1 ) (0.1 ) (0.1 ) (0.1 ) Other expense (income), net Amortization of net actuarial loss 1.7 1.7 3.4 3.3 Other expense (income), net Net periodic benefit cost $ 6.2 $ 6.1 $ 12.4 $ 12.1 (a) Prior period presented reflects adoption of ASU 2017-07. For further discussion on the reclassification, refer to Note 1, Significant Accounting Policies. The following sets forth the information related to the contributions to the Company’s defined benefit plans for 2018 : (in millions) Pension Benefits Actual contributions through June 30, 2018 $ 7.7 Expected contributions for the remainder of the year 8.4 Total actual and expected contributions $ 16.1

RESTRUCTURING AND OTHER COSTS

RESTRUCTURING AND OTHER COSTS	6 Months Ended
	Jun. 30, 2018
Restructuring and Related Activities [Abstract]
RESTRUCTURING AND OTHER COSTS	RESTRUCTURING AND OTHER COSTS Restructuring Costs During the three and six months ended June 30, 2018 , the Company recorded net restructuring costs and other costs of $188.9 million and $199.1 million , respectively, which includes net restructuring costs of $3.4 million and $10.8 million , respectively. During the three and six months ended June 30, 2017 , the Company recorded net restructuring costs and other cost of $81.7 million and $84.8 million , respectively, which includes net restructuring costs of $1.5 million and $3.8 million , respectively. These costs are recorded in Restructuring and other costs on the Consolidated Statements of Operations and the associated liabilities are recorded in Accrued liabilities on the Consolidated Balance Sheets. At June 30, 2018 , the Company’s restructuring accruals were as follows: Severance (in millions) 2016 and 2017 Plans 2018 Plans Total Balance at December 31, 2017 $ 7.7 $ 48.2 $ — $ 55.9 Provisions 0.7 0.2 10.8 11.7 Amounts applied (1.8 ) (7.7 ) (5.9 ) (15.4 ) Change in estimates (0.1 ) (1.8 ) (0.2 ) (2.1 ) Balance at June 30, 2018 $ 6.5 $ 38.9 $ 4.7 $ 50.1 Lease/Contract Terminations (in millions) 2016 and 2017 Plans Total Balance at December 31, 2017 $ 0.4 $ 0.2 $ 0.6 Provisions 0.3 (0.1 ) 0.2 Amounts applied (0.5 ) (0.1 ) (0.6 ) Balance at June 30, 2018 $ 0.2 $ — $ 0.2 Other Restructuring Costs (in millions) 2016 and 2017 Plans 2018 Plans Total Balance at December 31, 2017 $ 2.1 $ 1.7 $ — $ 3.8 Provisions 0.2 0.4 0.2 0.8 Amounts applied (1.5 ) (0.4 ) (0.2 ) (2.1 ) Balance at June 30, 2018 $ 0.8 $ 1.7 $ — $ 2.5 The following table provides the year-to-date changes in the restructuring accruals by segment: (in millions) December 31, 2017 Provisions Amounts Applied Change in Estimates June 30, 2018 Technologies & Equipment $ 46.9 $ 7.2 $ (7.9 ) $ (1.8 ) $ 44.4 Consumables 13.3 4.1 (8.2 ) (0.3 ) 8.9 All Other 0.1 1.4 (2.0 ) — (0.5 ) Total $ 60.3 $ 12.7 $ (18.1 ) $ (2.1 ) $ 52.8 Other Costs Other costs for the three and six months ended June 30, 2018 were $185.5 million and $188.3 million , respectively. Other costs for the three and six months ended June 30, 2017 were $80.2 million and $81.0 million , respectively. For the three months ended June 30, 2018 , the Company recorded an impairment charge of $ 179.2 million . The impaired indefinite-lived intangibles are tradenames and trademarks related to two reporting units within the Technologies & Equipment segment and one reporting unit within the Consumables segment. For further information, see Note 14, Goodwill and Intangibles. For the three months ended June 30, 2017 , the Company recorded an impairment charge of $79.8 million . The impaired indefinite-lived intangibles are tradenames and trademarks related to two reporting units within the Technologies & Equipment segment.

FINANCIAL INSTRUMENTS AND DERIV

FINANCIAL INSTRUMENTS AND DERIVATIVES	6 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS AND DERIVATIVES	FINANCIAL INSTRUMENTS AND DERIVATIVES Derivative Instruments and Hedging Activities The Company’s activities expose it to a variety of market risks, which primarily include the risks related to the effects of changes in foreign currency exchange rates and interest rates. These financial exposures are monitored and managed by the Company as part of its overall risk management program. The objective of this risk management program is to reduce the volatility that these market risks may have on the Company’s operating results and equity. The Company employs derivative financial instruments to hedge certain anticipated transactions, firm commitments, or assets and liabilities denominated in foreign currencies. Additionally, the Company utilizes interest rate swaps to convert variable rate debt to fixed rate debt. Derivative Instruments Designated as Hedging Cash Flow Hedges The following table summarizes the notional amounts of cash flow hedges by derivative instrument type at June 30, 2018 and the notional amounts expected to mature during the next 12 months, with a discussion of the various cash flow hedges by derivative instrument type following the table: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 301.4 $ 232.7 Interest rate swaps 113.2 — Total derivative instruments designated as cash flow hedges $ 414.6 $ 232.7 Foreign Exchange Risk Management The Company uses a layered hedging program to hedge select anticipated foreign currency cash flows to reduce volatility in both cash flows and reported earnings of the consolidated Company. The Company accounts for the designated foreign exchange forward contracts as cash flow hedges. As a result, the Company records the fair value of the contracts primarily through AOCI based on the assessed effectiveness of the foreign exchange forward contracts. The Company measures the effectiveness of cash flow hedges of anticipated transactions on a spot-to-spot basis rather than on a forward-to-forward basis. Accordingly, the spot-to-spot change in the derivative fair value will be deferred in AOCI and released and recorded on the Consolidated Statements of Operations in the same period that the hedged transaction is recorded. The time value component of the fair value of the derivative is deemed ineffective and is reported currently in Other expense (income), net on the Consolidated Statements of Operations in the period which it is applicable. Any cash flows associated with these instruments are included in cash from operating activities on the Consolidated Statements of Cash Flows. The Company hedges various currencies, with the most significant activity occurring in euros, Swedish kronor, Canadian dollars, British pounds, Swiss francs, Japanese yen and Australian dollars. These foreign exchange forward contracts generally have maturities up to 18 months and the counterparties to the transactions are typically large international financial institutions. Interest Rate Risk Management The Company uses interest rate swaps to convert a portion of its variable interest rate debt to fixed interest rate debt. At June 30, 2018 , the Company has one significant exposure hedged with interest rate contracts. The exposure is hedged with derivative contracts having notional amounts totaling 12.6 billion Japanese yen, which effectively converts the underlying variable interest rate debt facility to a fixed interest rate of 0.9% for an initial term of five years ending September 2019. The Company enters into interest rate swap contracts infrequently as they are only used to manage interest rate risk on long-term debt instruments and not for speculative purposes. Any cash flows associated with these instruments are included in cash from operating activities on the Consolidated Statements of Cash Flows. Cash Flow Hedge Activity The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to all cash flow hedges for the three months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ — Interest expense $ (0.6 ) $ — Foreign exchange forward contracts 2.8 Cost of products sold (4.2 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.3 ) Total in cash flow hedging $ 2.8 $ (4.8 ) $ (0.3 ) June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ (0.2 ) Interest expense $ (0.4 ) $ — Foreign exchange forward contracts (1.2 ) Cost of products sold 0.5 — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.2 ) Total for cash flow hedging $ (1.4 ) $ 0.1 $ (0.2 ) The following tables summarize the amount of gain (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to all cash flow hedges for the six months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ (0.1 ) Interest expense $ (1.1 ) $ — Foreign exchange forward contracts (4.1 ) Cost of products sold (6.1 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.4 ) Total in cash flow hedging $ (4.2 ) $ (7.2 ) $ (0.4 ) June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ — Interest expense $ (1.1 ) $ — Foreign exchange forward contracts (2.7 ) Cost of products sold 1.0 — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.5 ) Total for cash flow hedging $ (2.7 ) $ (0.1 ) $ (0.5 ) Overall, the derivatives designated as cash flow hedges are considered to be highly effective. At June 30, 2018 , the Company expects to reclassify $6.5 million of deferred net losses on cash flow hedges recorded in AOCI on the Consolidated Statements of Operations during the next 12 months. The term over which the Company is hedging exposures to variability of cash flows (for all forecasted transactions, excluding interest payments on variable interest rate debt) is typically 18 months. For the rollforward of derivative instruments designated as cash flow hedges in AOCI see Note 3 , Comprehensive Income. Hedges of Net Investments in Foreign Operations The Company has significant investments in foreign subsidiaries the most significant of which are denominated in euros, Swiss francs, Japanese yen and Swedish kronor. The net assets of these subsidiaries are exposed to volatility in currency exchange rates. The Company employs both derivative and non-derivative financial instruments to hedge a portion of this exposure. The derivative instruments consist of foreign exchange forward contracts and cross currency basis swaps. The non-derivative instruments consist of foreign currency denominated debt held at the parent company level. Translation gains and losses related to the net assets of the foreign subsidiaries are offset by gains and losses in derivative and non-derivative financial instruments designated as hedges of net investments, which are included in AOCI. Any cash flows associated with these instruments are included in investing activities on the Consolidated Statements of Cash Flows except for derivative instruments that include an other-than-insignificant financing element, for which all cash flows are classified as financing activities on the Consolidated Statements of Cash Flows. On January 2, 2018, the Company entered into a 245.6 million euro cross currency basis swap maturing in August 2021, that was designated as a hedge of net investments. This contract effectively converts the $295.7 million bond coupon from 4.1% to 1.7% , which will result in a net reduction of interest expense through maturity in 2021. The following table summarizes the notional amount of hedges of net investments by derivative instrument at June 30, 2018 and the notional amounts expected to mature during the next 12 months: Aggregate Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 600.6 $ 299.5 Cross currency basis swaps 286.5 — Total for instruments not designated as hedges $ 887.1 $ 299.5 The fair value of the foreign exchange forward contracts is the estimated amount the Company would receive or pay at the reporting date, taking into account the effective interest rates and foreign exchange rates. The effective portion of the change in the value of these derivatives is recorded in AOCI, net of tax effects. The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and Other expense (income), net on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the three months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Cross currency basis swaps $ 16.0 Interest expense $ 1.9 Foreign exchange forward contracts 31.3 Other expense (income), net 3.9 Total for net investment hedging $ 47.3 $ 5.8 June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Foreign exchange forward contracts $ (2.4 ) Other expense (income), net $ 0.3 Total for net investment hedging $ (2.4 ) $ 0.3 The following tables summarize the amount of gain (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the six months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Cross currency basis swaps $ 9.6 Interest expense $ 3.6 Other expense (income), net (6.6 ) Foreign exchange forward contracts 19.8 Other expense (income), net 5.4 Total for net investment hedging $ 29.4 $ 2.4 June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Foreign exchange forward contracts $ (4.2 ) Other expense (income), net $ 0.8 Total for net investment hedging $ (4.2 ) $ 0.8 Derivative Instruments Not Designated as Hedges The Company enters into derivative instruments with the intent to partially mitigate the foreign exchange revaluation risk associated with recorded assets and liabilities that are denominated in a non-functional currency. The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances and are recorded in Other expense (income), net on the Consolidated Statements of Operations. The Company primarily uses foreign exchange forward contracts and cross currency basis swaps to hedge these risks. Any cash flows associated with the foreign exchange forward contracts and interest rate swaps not designated as hedges are included in cash from operating activities on the Consolidated Statements of Cash Flows. Any cash flows associated with the cross currency basis swaps not designated as hedges are included in investing activities on the Consolidated Statements of Cash Flows except for derivative instruments that include an other-than-insignificant financing element, for which the cash flows are classified as financing activities on the Consolidated Statements of Cash Flows. The following tables summarize the aggregate notional amounts of the Company’s economic hedges not designated as hedges by derivative instrument types at June 30, 2018 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 388.0 $ 388.0 Total for instruments not designated as hedges $ 388.0 $ 388.0 The following table summarizes the amounts of gains (losses) recorded on the Company’s Consolidated Statements of Operations related to the economic hedges not designated as hedging for the three and six months ended June 30, 2018 and 2017 : Consolidated Statements of Operations Location Gain (Loss) Recognized Three Months Ended (in millions) 2018 2017 Foreign exchange forward contracts (a) Other expense (income), net $ 3.6 $ (2.3 ) Total for instruments not designated as hedges $ 3.6 $ (2.3 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in Other expense (income), net on the Consolidated Statements of Operations. Consolidated Statements of Operations Location Gain (Loss) Recognized Six Months Ended (in millions) 2018 2017 Foreign exchange forward contracts (a) Other expense (income), net $ 4.3 $ (5.1 ) Total for instruments not designated as hedges $ 4.3 $ (5.1 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in Other expense (income), net on the Consolidated Statements of Operations. Consolidated Balance Sheets Location of Derivative Fair Values The following tables summarize the fair value and the location of the Company’s derivatives on the Consolidated Balance Sheets at June 30, 2018 and December 31, 2017 : June 30, 2018 (in millions) Prepaid Expenses and Other Current Assets, Net Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 11.4 $ 10.4 $ 6.5 $ 1.0 Interest rate swaps — — 0.3 — Cross currency basis swaps — 3.0 — — Total $ 11.4 $ 13.4 $ 6.8 $ 1.0 Not Designated as Hedges Foreign exchange forward contracts $ 2.7 $ — $ 4.3 $ — Total $ 2.7 $ — $ 4.3 $ — December 31, 2017 (in millions) Prepaid Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 1.4 $ — $ 13.4 $ 4.5 Interest rate swaps — — 0.3 0.1 Total $ 1.4 $ — $ 13.7 $ 4.6 Not Designated as Hedges Foreign exchange forward contracts $ 3.4 $ — $ 3.7 $ — Total $ 3.4 $ — $ 3.7 $ — Balance Sheet Offsetting Substantially all of the Company’s derivative contracts are subject to netting arrangements, whereby the right to offset occurs in the event of default or termination in accordance with the terms of the arrangements with the counterparty. While these contracts contain the enforceable right to offset through netting arrangements with the same counterparty, the Company elects to present them on a gross basis on the Consolidated Balance Sheets. Offsetting of financial assets and liabilities under netting arrangements at June 30, 2018 : Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 24.9 $ — $ 24.9 $ (9.5 ) $ — $ 15.4 Cross currency basis swaps 3.0 — 3.0 (2.7 ) — 0.3 Total Assets $ 27.9 $ — $ 27.9 $ (12.2 ) $ — $ 15.7 Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 12.2 $ — $ 12.2 $ (12.0 ) $ — $ 0.2 Interest rate swaps 0.3 — 0.3 (0.2 ) — 0.1 Total Liabilities $ 12.5 $ — $ 12.5 $ (12.2 ) $ — $ 0.3 Offsetting of financial assets and liabilities under netting arrangements at December 31, 2017 : Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 4.8 $ — $ 4.8 $ (3.9 ) $ — $ 0.9 Total Assets $ 4.8 $ — $ 4.8 $ (3.9 ) $ — $ 0.9 Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 21.6 $ — $ 21.6 $ (3.8 ) $ — $ 17.8 Interest rate swaps 0.4 — 0.4 (0.1 ) — 0.3 Total Liabilities $ 22.0 $ — $ 22.0 $ (3.9 ) $ — $ 18.1

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENT	FAIR VALUE MEASUREMENT The Company records financial instruments at fair value with unrealized gains and losses related to certain financial instruments reflected in AOCI on the Consolidated Balance Sheets. In addition, the Company recognizes certain liabilities at fair value. The Company applies the market approach for recurring fair value measurements. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities that are recorded at fair value as of the balance sheet date are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The fair value of financial instruments is determined by reference to various market data and other valuation techniques as appropriate. The Company believes the carrying amounts of cash and cash equivalents, accounts receivable (net of allowance for doubtful accounts), prepaid expenses and other current assets, accounts payable, accrued liabilities, income taxes payable and notes payable approximate fair value due to the short-term nature of these instruments. The Company estimated the fair value using Level 1 inputs and carrying value of total long-term debt, including the current portion, was $ 1,598.5 million and $ 1,595.4 million , respectively at June 30, 2018 . At December 31, 2017 , the Company estimated the fair value and carrying value, including the current portion, was $ 1,629.9 million and $ 1,620.8 million , respectively. The variable interest rate on the Japanese yen term loan is consistent with current market conditions, therefore the fair value approximates the loan’s carrying value. The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at June 30, 2018 and December 31, 2017 : June 30, 2018 (in millions) Total Level 1 Level 2 Level 3 Assets Cross currency basis swaps $ 3.0 $ — $ 3.0 $ — Foreign exchange forward contracts 24.5 — 24.5 — Total assets $ 27.5 $ — $ 27.5 $ — Liabilities Interest rate swaps $ 0.3 $ — $ 0.3 $ — Foreign exchange forward contracts 11.8 — 11.8 — Contingent considerations on acquisitions 8.8 — — 8.8 Total liabilities $ 20.9 $ — $ 12.1 $ 8.8 December 31, 2017 (in millions) Total Level 1 Level 2 Level 3 Assets Foreign exchange forward contracts $ 4.8 $ — $ 4.8 $ — Available-for-sale security 54.4 — 54.4 — Total assets $ 59.2 $ — $ 59.2 $ — Liabilities Interest rate swaps $ 0.4 $ — $ 0.4 $ — Foreign exchange forward contracts 21.6 — 21.6 — Contingent considerations on acquisitions 8.6 — — 8.6 Total liabilities $ 30.6 $ — $ 22.0 $ 8.6 There have been no transfers between levels during the six months ended June 30, 2018 and 2017 . Derivative valuations are based on observable inputs to the valuation model including interest rates, foreign currency exchange rates and credit risks. The Company utilizes interest rate swaps and foreign exchange forward contracts that are considered cash flow hedges. In addition, the Company at times employs forward exchange contracts that are considered hedges of net investment in foreign operations. Designated derivative instruments are further discussed in Note 10 , Financial Instruments and Derivatives. The Company’s Level 3 liabilities at June 30, 2018 and December 31, 2017 are related to earn-out obligations on prior acquisitions. The following table presents a reconciliation of the Company’s Level 3 holdings measured at fair value on a recurring basis using unobservable inputs: Earn-out (in millions) Obligations Balance at December 31, 2017 $ 8.6 Fair value adjustment: Reported in Other expense (income), net 0.4 Effect of exchange rate changes (0.2 ) Balance at June 30, 2018 $ 8.8 For the six months ended June 30, 2018 , there were no other purchases, issuances or transfers of Level 3 financial instruments.

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Uncertainties in Income Taxes The Company recognizes in the interim consolidated financial statements, the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. It is reasonably possible that certain amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date of the Company’s interim consolidated financial statements. Final settlement and resolution of outstanding tax matters in various jurisdictions during the next twelve months are not expected to be significant. Other Tax Matters During the quarter ended June 30, 2018 , the Company recorded the following discrete tax items, $ 0.5 million of excess tax benefit related to employee share-based compensation, tax benefits of $0.7 million related to valuation allowances, $ 2.5 million related to enacted statutory rate changes and $ 0.6 million of tax benefit for other discrete tax matters. The Company also recorded a $50.4 million tax benefit as a discrete item related to the indefinite-lived intangible asset impairment charge, $1.1 million for the fixed asset impairment charge, and $3.3 million related to goodwill that was tax-deductible for the three months ended June 30, 2018. In addition the Company also recorded a $0.6 million tax benefit as a discrete item related to the gain on sale of marketable securities. During the quarter ended June 30 2017, the Company recorded the following discrete tax items, $4.2 million of excess tax benefit related to employee share-based compensation, $0.5 million of tax expense related to enacted statutory rate changes and $1.5 million of tax expense for other discrete tax matters. The Company also recorded a $23.5 million tax benefit as a discrete item related to the indefinite-lived intangible asset impairment charge recorded during the three months ended June 30, 2017. The goodwill impairment charge for the quarter ended June 30, 2017 was non-deductible for income tax purposes. U.S. Federal Legislative Changes On December 22, 2017, the Tax Cuts and Jobs Act (the "Act" or "U.S. tax reform") was enacted. U.S. tax reform, among other things, reduced the U.S. federal income tax rate to 21% in 2018 from 35%, instituted a dividends received deduction for foreign earnings with a related tax for the deemed repatriation of unremitted foreign earnings and created a new U.S. minimum tax on earnings of foreign subsidiaries. In addition, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for enactment effects of the Act and provides a measurement period of up to one year from the Act’s enactment date for companies to complete their accounting under Accounting Standards Codification No. 740 “Income Taxes”, (“ASC 740”). In accordance with SAB 118, to the extent that a company’s accounting for certain income tax effects of the Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in its financial statements. If a company cannot determine a provisional estimate to be included in its financial statements, it should continue to apply ASC 740 on the basis of the provisions of the tax laws that were in effect immediately before the enactment of the Act. The Company has accounted for the tax effects of the Act on a provisional basis. At December 31, 2017, the accounting for certain income tax effects was incomplete, but the Company determined reasonable estimates for those effects which were included in the financial statements. The Company expects to complete the accounting during 2018 to comply with the one year measurement period. Based on information available, at December 31, 2017, the Company estimated the cumulative undistributed foreign earnings and recorded a provisional estimate of income tax expense related to the one-time deemed repatriation toll charge. There is still uncertainty as to the application of the Act, in particular as it relates to state income taxes. Further, the Company has not yet completed the analysis of the components of the computation, including the amount of the foreign earnings subject to U.S. income tax, and the portion of the foreign earnings held in cash or other specified assets. At June 30, 2018, the estimated cash liability for the deemed repatriation of foreign earnings is approximately $1.0 million primarily due to the utilization of foreign tax credit carryforwards and certain other tax attributes. However, as the Company completes its analysis an additional liability could be recorded and the Company would elect to make installment payments as allowed under the Act. As a result of the Act, the Company can repatriate the cumulative undistributed foreign earnings back to the U.S. when needed with minimal U.S. income tax consequences other than the one-time deemed repatriation toll charge. The Company is still evaluating whether to change its indefinite reinvestment assertion in light of the Act and consider that conclusion to be incomplete in accordance SAB 118. For the Global Intangible Low Tax Income (“GILTI”) provision of the Act, the Company recorded an estimate for the six months ended June 30, 2018, as a period expense based on current guidance, but the Company has not yet completed its assessment or elected an accounting policy to either recognize deferred taxes for basis differences expected to reverse as GILTI or to record GILTI as period costs if and when incurred. In accordance with SEC guidance, provisional amounts may be refined as a result of additional guidance from, and interpretations by, U.S. regulatory and standard-setting bodies, and changes in assumptions. In subsequent periods, provisional amounts will be adjusted for the effects, if any, of interpretative guidance issued by the U.S. Department of the Treasury. The effects of the Act may be subject to changes for items that were previously reported as provisional amounts, as well as any element of the Act that a provisional estimate could not be made, and such changes could be material.

FINANCING ARRANGEMENTS

FINANCING ARRANGEMENTS	6 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
FINANCING ARRANGEMENTS	FINANCING ARRANGEMENTS The Company’s revolving credit facility, term loans and Senior Notes contain certain affirmative and negative covenants relating to the Company's operations and financial condition. At June 30, 2018 , the Company was in compliance with all debt covenants. At June 30, 2018 , there were no outstanding borrowings under the current $ 500.0 million multi-currency revolving credit facility. During the quarter ended June 30, 2018 , the Company had issued $ 205.0 million of Commercial Paper which was outstanding at June 30, 2018. The multi-currency revolving credit facility serves as a back-stop facility for the Company’s $ 500.0 million Commercial Paper program. On July 27, 2018, the Company amended and extended its $ 500.0 million multicurrency revolving credit facility increasing the total available to $700.0 million through July 27, 2023. In addition, certain new lenders joined the bank group. The Company has access to the full $ 700.0 million through July 27, 2023. The facility is unsecured and contains certain affirmative and negative covenants relating to the operations and financial condition of the Company. The most restrictive of these covenants pertain to asset dispositions and prescribed ratios of indebtedness to total capital and operating income, plus depreciation and amortization to interest expense. At June 30, 2018 , the Company had $ 322.9 million of borrowing available under lines of credit, including lines available under its short-term arrangements and revolving credit agreement.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The Company performed its annual impairment tests of goodwill as of April 30, 2018 on 11 reporting units. To determine the fair value of the Company’s reporting units, the Company uses a discounted cash flow model with market-based support as its valuation technique to measure the fair value for its reporting units. The discounted cash flow model uses five - to ten - year forecasted cash flows plus a terminal value based on a multiple of earnings or by capitalizing the last period’s cash flows using a perpetual growth rate. In the development of the forecasted cash flows, the Company applies revenue, gross profit and operating expense assumptions taking into consideration historical trends as well as future expectations. These future expectations include, but are not limited to, new product development and distribution channel changes for the respective reporting units. The Company also considers the current and projected market conditions for dental and medical device industries, both in the U.S. and globally, when determining its assumptions. The total forecasted cash flows are discounted based on a range between 7.9% to 10.5% . The discount rate used is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the reporting unit’s ability to execute on the projected cash flows. The Company’s significant estimates in the discounted cash flow models include, but is not limited to, the weighted average cost of capital, long-term rate of growth and profitability of the reporting unit’s business and working capital effects. A change in any of these estimates and assumptions could produce a different fair value, which could have a material impact on the Company’s results of operations. Unfavorable developments in the market for the dental or medical device industries, an increase in discount rates, unfavorable changes in earnings multiples or a decline in future cash flow projections, among other factors, may cause a change in circumstances indicating that the carrying value of the indefinite-lived assets and goodwill within the Company’s reporting units may not be recoverable. In connection with the updating of the estimates and assumptions with the annual impairment tests of goodwill and the preparation of the financial statements for the three months ended June 30, 2018, the Company determined that the goodwill associated with the CAD/CAM, Imaging and Orthodontics reporting units was impaired. Additionally, near the end of the quarter, the Company recognized that the CAD/CAM and Imaging reporting units’ (“equipment reporting units”) revenue and operating margins would not meet forecasted expectations for the quarter as a result of several significant unfavorable developments which also affected the reporting units’ projections for future revenue and operating margins. As a result, the Company recorded a goodwill impairment charge of $1,085.8 million . The CAD/CAM and Imaging reporting units are within the Technologies & Equipment segment and the Orthodontics reporting unit is within the Consumables segment. The significant unfavorable developments in the current period which are reflected in the Company’s April 30, 2018 goodwill impairment testing model, are as follows: • The equipment reporting units were negatively affected in connection with the continued transition of the Company’s distribution relationships primarily in the U.S. from exclusive to non-exclusive. The Company’s expectations for revenue growth from its non-exclusive distribution relationships, which replaced its former long-term exclusive distribution relationship, were not met. As a result, the Company’s forecasts of current and future third-party demand have been reduced as the Company’s U.S. distributors continue to offer and promote competitive alternatives to the Company’s full CAD/CAM systems and lower-priced alternatives to the Imaging reporting units’ products. • The Imaging reporting unit observed revenue and operating margins being negatively impacted by aggressive competition with a focus on value-based products in the marketplace as opposed to the reporting unit’s premium products. This has resulted in increased competition from low-cost products in certain regions throughout the world causing the reporting unit to offer additional product features at the current price levels and to offer additional promotions and reduce its future sales forecasts. • The CAD/CAM and Imaging reporting units have also experienced lower than expected sales with respect to higher margin products as well as a regional shift in sales to emerging markets each of which has negatively impacted the reporting units’ overall operating margins as compared to the original forecasts for the period and for future sales forecasts. • The equipment reporting units were also further impacted by the unfavorable change in the discount rate due primarily to a higher risk factor, which represents management’s assessment of increased risk with respect to the CAD/CAM and Imaging reporting units’ forecasts primarily due to the factors described above, and to a lesser extent a higher risk-free interest rate for all reporting units. • The increased reduction of inventory being held by the Company’s U.S. distributors in the second quarter, which was larger than anticipated for the period, and planned further reductions of inventory, will impact the Company’s near-term results. As a result of the factors described above, and the resulting reduced revenue and profitability expectations for these reporting units, we have forecasted reductions in unit volume growth rates and operating margins and lower future cash flows used to estimate the fair value of these reporting units, which resulted in a determination that an impairment adjustment was required. The Orthodontics reporting unit goodwill impairment charge was primarily driven by lower operating margins and lower sales growth. The products manufactured and sold within this reporting unit have consisted mainly of traditional orthodontic treatment products, i.e., brackets, bands and wires. The impairment charge is unrelated to the Company’s acquisition of OraMetrix. The Company has observed a continuing decline in operating margins as the marketplace has seen higher than expected price competition primarily due to increased supply of traditional orthodontic products in the market. In addition, the Company has seen lower than expected revenue growth which is reflected in its future forecast. The Company believes the revenue trend is the result of competition as well as the growing end-user demand for newer orthodontic treatment options. For the Company’s reporting units that were not impaired, the Company applied a hypothetical sensitivity analysis. Had the discount rate of each of these reporting units been hypothetically increased by 100 basis points at April 30, 2018, the fair value of one reporting unit, Treatment Centers, would not exceed net book value. If the fair value of each of these reporting units had been hypothetically reduced by 10% at April 30, 2018, the fair value of one reporting unit, Treatment Centers, would not exceed net book value. Goodwill for the Treatment Centers reporting unit totals $292.7 million at June 30, 2018. In conjunction with the goodwill and indefinite-lived intangibles impairment test, the Company utilized its best estimate of future cash flows as of April 30, 2018, which include significant management assumptions such as future revenue growth rates, operating margins, weighted average cost of capital, and future economic and market conditions affecting the dental and medical device industries. Any changes to these assumptions and estimates could have a negative impact on the fair value of these reporting units and may result in further impairment. Given the uncertainty in the marketplace and other factors affecting management’s assumptions underlying the Company’s discounted cash flow model, these estimates could vary significantly in the future, which may result in a goodwill impairment charge at that time. The goodwill impairment charge is not expected to result in future cash expenditures. The Company also assessed the annual impairment of indefinite-lived intangible assets as of April 30, 2018, which largely consists of acquired tradenames, in conjunction with the annual impairment tests of goodwill. As a result of the annual impairment tests of indefinite-lived intangible assets, the Company recorded an impairment charge of $179.2 million for the three months ended June 30, 2018 which was recorded in Restructuring and other costs on the Consolidated Statements of Operations. The impaired indefinite-lived intangible assets are tradenames and trademarks related to the CAD/CAM, Imaging, and Instrument reporting units. The impairment charge was primarily driven by a decline in forecasted sales resulting from increased competition and the impact of low-cost competitive products, as discussed above with respect to goodwill. In addition, the unfavorable impact of an increase in the equipment reporting units’ respective risk factors, along with increases in the risk-free rate, increased the discount rate. The assumptions and estimates used in determining the fair value of the indefinite-lived intangible assets contain uncertainties, and any changes to these assumptions and estimates could have a negative impact and result in a future impairment. A reconciliation of changes in the Company’s goodwill by reportable segment is as follows: (in millions) Technologies & Equipment Consumables Total Balance at December 31, 2017 $ 3,660.6 $ 878.6 $ 4,539.2 Acquisition related additions — 66.5 66.5 Measurement period adjustments on prior acquisitions — 0.5 0.5 Impairment (1,017.2 ) (68.5 ) (1,085.7 ) Effects of exchange rate changes (51.3 ) (11.4 ) (62.7 ) Balance at June 30, 2018 $ 2,592.1 $ 865.7 $ 3,457.8 The following table provides the gross carrying amount of goodwill and the cumulative goodwill impairment: June 30, 2018 December 31, 2017 (in millions) Gross Carrying Amount Cumulative Impairment Net Carrying Amount Gross Carrying Amount Cumulative Impairment Net Carrying Amount Technologies & Equipment $ 5,260.2 $ (2,668.1 ) $ 2,592.1 $ 5,311.5 $ (1,650.9 ) $ 3,660.6 Consumables 934.2 (68.5 ) 865.7 878.6 — 878.6 Total effect of cumulative impairment 6,194.4 (2,736.6 ) 3,457.8 6,190.1 (1,650.9 ) 4,539.2 Identifiable definite-lived and indefinite-lived intangible assets consist of the following: June 30, 2018 December 31, 2017 (in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Patents and developed technology $ 1,416.1 $ (353.5 ) $ 1,062.6 $ 1,385.5 $ (305.0 ) $ 1,080.5 Trademarks 82.6 (61.5 ) 21.1 76.4 (46.5 ) 29.9 Licensing agreements 36.1 (25.4 ) 10.7 31.2 (24.8 ) 6.4 Customer relationships 1,098.8 (301.8 ) 797.0 1,109.1 (272.0 ) 837.1 Total definite-lived $ 2,633.6 $ (742.2 ) $ 1,891.4 $ 2,602.2 $ (648.3 ) $ 1,953.9 Indefinite-lived tradenames and trademarks $ 655.4 $ — $ 655.4 $ 846.8 $ — $ 846.8 Total identifiable intangible assets $ 3,289.0 $ (742.2 ) $ 2,546.8 $ 3,449.0 $ (648.3 ) $ 2,800.7

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Litigation The SEC’s Division of Enforcement has asked the Company to provide documents and information concerning the Company’s accounting and disclosures. The Company is cooperating with the SEC’s investigation. The Company is unable to predict the ultimate outcome of this matter, or whether it will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. On May 5, 2015, Roth Licensing, LLC (“Roth Licensing”) filed a demand for arbitration alleging that GAC International, LLC, a subsidiary of the Company (“GAC”), infringes a registered trademark of Roth Licensing pursuant to the Lanham Act, California Civil Code Section 3344.1, and certain other common law causes of action. On August 9, 2017, the arbitrator issued an interim decision on liability finding that GAC had willfully infringed the registered trademark of Roth Licensing. On November 8, 2017, the arbitrator served his Final Award on damages awarding Roth Licensing approximately $ 16.0 million for damages, attorneys’ fees and costs as well as injunctive relief regarding the ROTH mark and any reproduction, counterfeit, copy, or colorable imitation of the ROTH mark and Dr. Roth’s image. The Company believes that the arbitrator failed to follow the applicable arbitration procedures, and it has filed a Motion to Vacate Arbitration Award with the Eastern District of New York. On January 11, 2018, Thomas Redlich, a former employee, filed a lawsuit against the Company, demanding supplemental compensation pursuant to an agreement allegedly entered into with Sirona Dental GmbH which was intended to entice Mr. Redlich to continue to work for the company for no less than eight years following the date of this agreement. The Company filed its response on April 4, 2018, denying the authenticity and enforceability of, and all liability under, the alleged agreement. The Court held an initial hearing on the matter on April 11, 2018, allowing Mr. Redlich to file a reply to the Company’s response on July 9, 2018, and allowing the Company to respond to that reply. The Court has set a further hearing on August 30, 2018 for this matter. The Company intends to defend this claim vigorously. On January 25, 2018, Futuredontics, Inc. received service of a purported class action lawsuit brought by Henry Olivares and other similarly situated individuals in the Superior Court of the State of California for the County of Los Angeles. The plaintiff class alleges several violations of the California wage and hours laws, including, but not limited to, failure to provide rest and meal breaks and the failure pay overtime. The Company has filed its answer to the complaint and the parties have initiated written and other discovery. The Company continues to vigorously defend against this matter. On June 7, 2018, John Castronovo filed a putative class action suit in the County of New York alleging that the Company and certain of its present and former officers and directors violated U.S. securities laws by allegedly making false and misleading statements in connection with a February 2016 registration statement issued in connection with the acquisition of and merger with former Sirona Dental Systems, Inc. by former Dentsply International Inc. The Company intends to defend itself vigorously. In addition to the matters disclosed above, the Company is, from time to time, subject to a variety of litigation and similar proceedings incidental to its business. These legal matters primarily involve claims for damages arising out of the use of the Company’s products and services and claims relating to intellectual property matters including patent infringement, employment matters, tax matters, commercial disputes, competition and sales and trading practices, personal injury and insurance coverage. The Company may also become subject to lawsuits as a result of past or future acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, divested businesses. Some of these lawsuits may include claims for punitive and consequential, as well as compensatory damages. Based upon the Company’s experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its consolidated results of operations, financial position or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. While the Company maintains general, product, property, workers’ compensation, automobile, cargo, aviation, crime, fiduciary and directors’ and officers’ liability insurance up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses. In addition, while the Company believes it is entitled to indemnification from third parties for some of these claims, these rights may also be insufficient or unavailable to cover such losses. Purchase Commitments From time to time, the Company enters into long-term inventory purchase commitments with minimum purchase requirements for raw materials and finished goods to ensure the availability of products for production and distribution. These commitments may have a significant impact on levels of inventory maintained by the Company.

SIGNIFICANT ACCOUNTING POLICI23

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of risk and/or control of Dental and Healthcare Consumables products (“consumable” products), Dental Technology products (“technology” products), or Dental Equipment products (“equipment” products). Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Sales, value add and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. For most of consumable, technology and equipment products, the Company transfers control and recognizes a sale when products are shipped from the manufacturing facility or warehouse to the customer (distributors and direct to dentists). For contracts with customers that contain destination shipping terms, revenue is not recognized until risk has transferred and the goods are delivered to the agreed upon destination. The amount of consideration received and revenue recognized varies with changes in marketing incentives (e.g., discounts, rebates, free goods) and returns offered to customers and their customers. When the Company gives customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty related returns, are infrequent and insignificant. The Company adjusts the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Depending on the terms of the arrangement, the Company will defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied (e.g., extended maintenance/service contracts, software and licenses, customer loyalty points and coupon programs). The Company uses an observable price, typically average selling price, to determine the stand-alone selling price for separate performance obligations. The Company determines the stand-alone selling price, based on Company geographic sales locations’ database of pricing and discounting practices for the specific product or service when sold separately, and utilizes this data to arrive at average selling prices by product. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to the unsatisfied performance obligation, which is deferred until satisfied. At June 30, 2018, the Company had $26.2 million of deferred revenue recorded in Accrued liabilities on the Consolidated Balance Sheets. The Company expects to recognize significantly all of the deferred revenue within the next twelve months. The Company has elected to account for shipping and handling activities as a fulfillment cost within the cost of products sold, and records shipping and handling costs collected from customers in net sales. The Company has adopted two practical expedients: the “right to invoice” practical expedient, which allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date; and relief from considering the existence of a significant financing component when the payment for the good or service is expected to be one year or less. The Company offers discounts to its customers and distributors if certain conditions are met. Discounts are primarily based on the volume of products purchased or targeted to be purchased by the customer. Discounts are deducted from revenue at the time of sale or when the discount is offered, whichever is later. The Company estimates volume discounts based on an individual customer’s historical and estimated future product purchases. Certain of the Company’s customers are offered cash rebates based on targeted sales increases. The Company estimates rebates based on the forecasted performance of a customer and their expected level of achievement within the rebate programs. In accounting for these rebate programs, the Company records an accrual and reduces sales ratably as sales occur over the rebate period. The Company updates the accruals for these rebate programs as actual results and updated forecasts impact the estimated achievement for customers within the rebate programs. A portion of the Company’s net sales is comprised of sales of precious metals generated through its precious metal dental alloy product offerings. As the precious metal content of the Company’s sales is largely a pass-through to customers, the Company uses its cost of precious metal purchased as a proxy for the precious metal content of sales, as the precious metal content of sales is not separately tracked and invoiced to customers. The Company believes that it is reasonable to use the cost of precious metal content purchased in this manner since precious metal alloy sale prices are typically adjusted when the prices of underlying precious metals change.
Accounts and Notes Receivable	Accounts and Notes Receivable The Company records a provision for doubtful accounts, which is included in Selling, general and administrative expenses on the Consolidated Statements of Operations.
Income Taxes	Income Taxes The Company has accounted for the tax effects of the Tax Cuts and Jobs Act, enacted on December 22, 2017, on a provisional basis. At December 31, 2017, the accounting for certain income tax effects was incomplete, but the Company determined reasonable estimates for those effects which were included in the financial statements. The Company expects to complete the accounting during 2018 in accordance with the one year measurement period.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements Effective January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers”, as amended (Topic 606, commonly referred to as ASC 606) to all contracts using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Most of the Company’s sales revenue continues to be recognized when products are shipped from manufacturing facilities. For certain customer and dealer incentive programs, such as coupons, customer loyalty and free goods, the Company recognizes the proportionate revenue and cost of product when the incentives are shipped or awarded. Prior to adoption of ASC 606, costs for these types of programs were recognized when triggering events occurred. For contracts with customers where performance occurs over time, such as software sales, the Company recognizes revenue ratably over the performance period. The new revenue standard also provided additional guidance that resulted in reclassifications to or from Net sales, Cost of products sold, Selling, general and administrative expenses, and the resultant change in Provision (benefit) for income taxes. The cumulative effect of the changes made on the Consolidated Balance Sheets at December 31, 2017 for the adoption of ASC 606, is as follows: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASC 606 January 1, 2018 Revised Balance Assets Accounts and notes receivable-trade, net $ 746.2 $ 0.2 $ 746.4 Inventory, net 623.1 (0.3 ) 622.8 Prepaid expense and other current assets, net 312.6 1.9 314.5 Liabilities and Equity Accrued liabilities 585.8 9.9 595.7 Income taxes payable 54.2 (2.1 ) 52.1 Retained earnings 2,316.2 (6.0 ) 2,310.2 The impact of adopting the new revenue recognition standard on the Company’s Consolidated Statements of Operations and Consolidated Balance Sheets is as follows: (in millions) Three Months Ended June 30, 2018 Six Months Ended June 30, 2018 Consolidated Statements of Operations Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Net sales $ 1,042.1 $ 1,044.8 $ (2.7 ) $ 1,998.2 $ 1,998.8 $ (0.6 ) Cost of products sold 489.3 491.4 (2.1 ) 931.3 930.3 1.0 Selling, general and administrative expenses 432.2 432.3 (0.1 ) 867.4 868.1 (0.7 ) Provision (benefit) for income taxes (41.3 ) (41.2 ) (0.1 ) (27.6 ) (27.4 ) (0.2 ) Net loss attributable to Dentsply Sirona (1,122.0 ) (1,121.6 ) (0.4 ) (1,040.8 ) (1,040.1 ) (0.7 ) (in millions) Balance at June 30, 2018 Consolidated Balance Sheets Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Assets Accounts and notes receivables-trade, net $ 710.3 $ 710.2 $ 0.1 Inventories, net 666.3 666.6 (0.3 ) Prepaid expenses and other current assets, net 276.5 273.4 3.1 Liabilities and Equity Accrued liabilities 575.3 563.4 11.9 Income taxes payable 31.9 34.2 (2.3 ) Retained earnings 1,216.2 1,222.9 (6.7 ) Effective January 1, 2018, the Company adopted ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” This accounting standard seeks to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Previously, US GAAP prohibited the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to a third party, which is an exception to the principle of comprehensive recognition of current and deferred income taxes in US GAAP. ASU No. 2016-16 eliminates this exception. The Company adopted this accounting standard using the modified retrospective method with a cumulative-effect adjustment directly to retained earnings. Upon adoption, the Company made the following reclassification: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASU 2016-16 Increase/(Decrease) January 1, 2018 Revised Balance Assets Prepaid expenses and other current assets, net $ 312.6 $ (5.6 ) $ 307.0 Other noncurrent assets, net 156.1 (73.1 ) 83.0 Liabilities and Equity Deferred income taxes 718.0 (76.0 ) 642.0 Retained earnings 2,316.2 (2.7 ) 2,313.5 In March 2017, the FASB issued ASU No. 2017-07, “Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.” This newly issued accounting standard is primarily intended to improve the presentation of net periodic pension cost and net periodic postretirement benefit cost. The amendments in this update require an employer to report the service cost component of net periodic benefit cost in operating income, while the interest cost, amortization, return on assets and any settlement or curtailment expense will be reported below operating income. More specifically, the service cost will be reported in the same line item as other compensation costs arising from the services rendered by the pertinent employee during the period. The amendments in this update are required for annual and interim periods beginning after December 15, 2017, and should be applied retrospectively for the presentation of the components of net periodic benefit cost and net periodic postretirement benefit cost in the income statement. The amendment allows a practical expedient that permits an employer to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. The Company adopted this accounting standard on January 1, 2018, and applied the practical expedient upon adoption. The impact of adopting this standard, by financial statement line item, is reflected below: (in millions) Consolidated Statements of Operations Item Three Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Three Months Ended June 30, 2017 Revised Cost of products sold $ 448.5 $ (0.3 ) $ 448.2 Gross profit 544.2 0.3 544.5 Selling, general and administrative expense 417.6 (1.9 ) 415.7 Operating loss (1,048.0 ) 2.2 (1,045.8 ) Other expense (income), net 7.8 2.2 10.0 (in millions) Consolidated Statements of Operations Item Six Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Six Months Ended June 30, 2017 Revised Cost of products sold $ 857.0 $ (0.8 ) $ 856.2 Gross profit 1,036.2 0.8 1,037.0 Selling, general and administrative expense 822.3 (3.6 ) 818.7 Operating loss (963.8 ) 4.4 (959.4 ) Other expense (income), net 6.8 4.4 11.2 In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This newly issued accounting standard allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from tax rate changes due to the Tax Cuts and Jobs Act. The amendments in this update are required for annual and interim periods beginning after December 15, 2018. This standard also requires the Company to disclose its accounting policy for releasing income tax effects from accumulated other comprehensive income. In general, the Company applies the individual item approach. As permitted by the accounting standard, the Company early adopted this accounting standard on January 1, 2018. As a result of the adoption, the Company elected to reclassify the income tax effects from AOCI to Retained earnings and reclassified $8.1 million . Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) with subsequent amendments (collectively, “Topic 842”). This accounting standard seeks to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The adoption of this standard is required for interim and fiscal periods ending after December 15, 2018, using the modified retrospective approach. Topic 842 provides for an additional optional transition method that allows application of the new standard beginning January 1, 2019 with recognition of a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Periods prior to adoption would continue to conform to current US GAAP (Topic 840, Leases) and periods after adoptions would conform to Topic 842. The Company anticipates adopting Topic 842 using the optional transition method and is currently assessing the impact that this standard will have on its financial position, results of operations, cash flows and disclosures. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.” This newly issued accounting standard improves the financial reporting and disclosure of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. The amendments in this update make improvements to simplify the application of the hedge accounting guidance in current US GAAP based on the feedback received from preparers, auditors, users and other stakeholders. More specifically, this update expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. The amendments in this update are required for annual and interim periods beginning after December 15, 2018. Early adoption is permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. For cash flow and net investment hedges existing at the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the amendments in this update. The amended presentation and disclosure guidance is required only prospectively. The Company is currently assessing the impact that this standard will have on its financial position, results of operations, cash flows and disclosures.

SIGNIFICANT ACCOUNTING POLICI24

SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Schedule of Adjustments to the Financial Statement Line Items Impact by this Accounting Update	Upon adoption, the Company made the following reclassification: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASU 2016-16 Increase/(Decrease) January 1, 2018 Revised Balance Assets Prepaid expenses and other current assets, net $ 312.6 $ (5.6 ) $ 307.0 Other noncurrent assets, net 156.1 (73.1 ) 83.0 Liabilities and Equity Deferred income taxes 718.0 (76.0 ) 642.0 Retained earnings 2,316.2 (2.7 ) 2,313.5 The impact of adopting this standard, by financial statement line item, is reflected below: (in millions) Consolidated Statements of Operations Item Three Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Three Months Ended June 30, 2017 Revised Cost of products sold $ 448.5 $ (0.3 ) $ 448.2 Gross profit 544.2 0.3 544.5 Selling, general and administrative expense 417.6 (1.9 ) 415.7 Operating loss (1,048.0 ) 2.2 (1,045.8 ) Other expense (income), net 7.8 2.2 10.0 (in millions) Consolidated Statements of Operations Item Six Months Ended June 30, 2017 As Reported Adoption of 2017-07 Increase/(Decrease) Six Months Ended June 30, 2017 Revised Cost of products sold $ 857.0 $ (0.8 ) $ 856.2 Gross profit 1,036.2 0.8 1,037.0 Selling, general and administrative expense 822.3 (3.6 ) 818.7 Operating loss (963.8 ) 4.4 (959.4 ) Other expense (income), net 6.8 4.4 11.2 The cumulative effect of the changes made on the Consolidated Balance Sheets at December 31, 2017 for the adoption of ASC 606, is as follows: (in millions) Consolidated Balance Sheets Item December 31, 2017 As Reported Balance Adoption of ASC 606 January 1, 2018 Revised Balance Assets Accounts and notes receivable-trade, net $ 746.2 $ 0.2 $ 746.4 Inventory, net 623.1 (0.3 ) 622.8 Prepaid expense and other current assets, net 312.6 1.9 314.5 Liabilities and Equity Accrued liabilities 585.8 9.9 595.7 Income taxes payable 54.2 (2.1 ) 52.1 Retained earnings 2,316.2 (6.0 ) 2,310.2 The impact of adopting the new revenue recognition standard on the Company’s Consolidated Statements of Operations and Consolidated Balance Sheets is as follows: (in millions) Three Months Ended June 30, 2018 Six Months Ended June 30, 2018 Consolidated Statements of Operations Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Net sales $ 1,042.1 $ 1,044.8 $ (2.7 ) $ 1,998.2 $ 1,998.8 $ (0.6 ) Cost of products sold 489.3 491.4 (2.1 ) 931.3 930.3 1.0 Selling, general and administrative expenses 432.2 432.3 (0.1 ) 867.4 868.1 (0.7 ) Provision (benefit) for income taxes (41.3 ) (41.2 ) (0.1 ) (27.6 ) (27.4 ) (0.2 ) Net loss attributable to Dentsply Sirona (1,122.0 ) (1,121.6 ) (0.4 ) (1,040.8 ) (1,040.1 ) (0.7 ) (in millions) Balance at June 30, 2018 Consolidated Balance Sheets Item As Reported Balance Balances Without Adoption of ASC 606 Effect of Change Increase/(Decrease) Assets Accounts and notes receivables-trade, net $ 710.3 $ 710.2 $ 0.1 Inventories, net 666.3 666.6 (0.3 ) Prepaid expenses and other current assets, net 276.5 273.4 3.1 Liabilities and Equity Accrued liabilities 575.3 563.4 11.9 Income taxes payable 31.9 34.2 (2.3 ) Retained earnings 1,216.2 1,222.9 (6.7 )

STOCK COMPENSATION (Tables)

STOCK COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock Based Compensation	The following table represents total stock based compensation expense for non-qualified stock options, restricted stock units (“RSU”) and the tax related benefit for the three and six months ended June 30, 2018 and 2017 . Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Stock option expense $ 2.7 $ 2.5 $ 3.4 $ 5.2 RSU expense (2.6 ) 8.0 5.9 15.7 Total stock based compensation expense $ 0.1 $ 10.5 $ 9.3 $ 20.9 Related deferred income tax benefit $ — $ 2.5 $ 1.6 $ 5.8

COMPREHENSIVE INCOME (LOSS) (Ta

COMPREHENSIVE INCOME (LOSS) (Tables)	6 Months Ended
	Jun. 30, 2018
COMPREHENSIVE INCOME [Abstract]
Schedule of Components of Comprehensive Income	The following table summarizes the components of comprehensive income (loss), net of tax, for the three and six months ended June 30, 2018 and 2017 : Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Foreign currency translation gains $ — $ 248.2 $ — $ 304.8 Foreign currency translation losses (223.4 ) — (139.4 ) — Foreign currency translation gain on hedges of net investments 31.0 — 12.1 — Foreign currency translation loss on hedges of net investments — (24.2 ) — (33.6 )
Schedule of Accumulated Other Comprehensive Income (Loss)	Changes in AOCI, net of tax, by component for the six months ended June 30, 2018 and 2017 were as follows: (in millions) Foreign Currency Translation Gain (Loss) Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities Pension Liability Gain (Loss) Total Balance, net of tax, at December 31, 2017 $ (104.5 ) $ (12.6 ) $ (127.6 ) $ 44.3 $ (90.6 ) $ (291.0 ) Other comprehensive (loss) income before reclassifications and tax impact (106.6 ) (4.2 ) 29.4 — 2.4 (79.0 ) Tax (expense) benefit (20.7 ) 0.5 (14.5 ) (0.6 ) (35.3 ) Other comprehensive (loss) income, net of tax, before reclassifications (127.3 ) (3.7 ) 14.9 — 1.8 (114.3 ) Amounts reclassified from accumulated other comprehensive income (loss), net of tax — 6.4 — (44.3 ) 2.4 (35.5 ) Net (decrease) increase in other comprehensive income (127.3 ) 2.7 14.9 (44.3 ) 4.2 (149.8 ) Balance, net of tax, at June 30, 2018 $ (231.8 ) $ (9.9 ) $ (112.7 ) $ — $ (86.4 ) $ (440.8 ) (in millions) Foreign Currency Translation Gain (Loss) Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Pension Liability Gain (Loss) Total Balance, net of tax, at December 31, 2016 $ (490.5 ) $ (3.2 ) $ (116.8 ) $ (95.2 ) $ (705.7 ) Other comprehensive income (loss) before reclassifications and tax impact 245.8 (2.7 ) (4.2 ) — 238.9 Tax benefit 25.4 0.2 0.8 — 26.4 Other comprehensive income (loss), net of tax, before reclassifications 271.2 (2.5 ) (3.4 ) — 265.3 Amounts reclassified from accumulated other comprehensive income, net of tax — 0.1 — 2.3 2.4 Net increase (decrease) in other comprehensive income 271.2 (2.4 ) (3.4 ) 2.3 267.7 Balance, net of tax, at June 30, 2017 $ (219.3 ) $ (5.6 ) $ (120.2 ) $ (92.9 ) $ (438.0 )
Reclassification Out of Accumulated Other Comprehensive Income	Reclassifications out of AOCI to the Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 were as follows: (in millions) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item on the Consolidated Statements of Operations Three Months Ended 2018 2017 (Loss) gain on derivative financial instruments: Interest rate swaps $ (0.5 ) $ (0.4 ) Interest expense Foreign exchange forward contracts (4.3 ) 0.5 Cost of products sold Net (loss) gain before tax (4.8 ) 0.1 Tax impact 0.7 — Provision (benefit) for income taxes Net (loss) gain after tax $ (4.1 ) $ 0.1 Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ — $ 0.1 (a) Amortization of net actuarial losses (1.7 ) (1.7 ) (a) Net loss before tax (1.7 ) (1.6 ) Tax impact 0.5 0.5 Provision (benefit) for income taxes Net loss after tax $ (1.2 ) $ (1.1 ) Total reclassifications for the period $ (5.3 ) $ (1.0 ) (a) These AOCI components are included in the computation of net periodic benefit cost for the three months ended June 30, 2018 and 2017 (see Note 8 , Benefit Plans, for additional details). (in millions) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item on the Consolidated Statements of Operations Six Months Ended 2018 2017 Loss on derivative financial instruments: Interest rate swaps $ (1.1 ) $ (1.1 ) Interest expense Foreign exchange forward contracts (6.1 ) 1.0 Cost of products sold Net loss before tax (7.2 ) (0.1 ) Tax impact 0.8 — Provision (benefit) for income taxes Net loss after tax $ (6.4 ) $ (0.1 ) Net realized holding gain on available-for-sale securities: Available-for-sale securities $ 45.0 $ — Other expense (income), net Tax impact (0.7 ) — Provision (benefit) for income taxes Net gain after tax $ 44.3 $ — Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ — $ 0.1 (a) Amortization of net actuarial losses (3.4 ) (3.4 ) (a) Net loss before tax (3.4 ) (3.3 ) Tax impact 1.0 1.0 Provision (benefit) for income taxes Net loss after tax $ (2.4 ) $ (2.3 ) Total reclassifications for the period $ 35.5 $ (2.4 ) (a) These AOCI components are included in the computation of net periodic benefit cost for the six months ended June 30, 2018 and 2017 (see Note 8 , Benefit Plans, for additional details).

BUSINESS COMBINATIONS (Tables)

BUSINESS COMBINATIONS (Tables)	6 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
Summary of Intangible Assets Acquired	Intangible assets acquired consist of the following: Weighted Average Useful Life (in millions, except for useful life) Amount (in years) Customer relationships $ 17.5 15 Developed technology and patents 63.4 15 Trade names and trademarks 12.8 Indefinite Total $ 93.7 Intangible assets acquired consist of the following: Weighted Average Useful Life (in millions, except for useful life) Amount (in years) Customer relationships $ 18.1 15 Developed technology and patents 22.4 15 Trade names and trademarks 8.5 Indefinite Total $ 49.0

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
Third Party Net Sales	The following tables set forth information about the Company’s segments for the three and six months ended June 30, 2018 and 2017 . Certain reclassifications have been made to the prior year’s data in order to conform to the current year presentation: Third Party Net Sales Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 548.8 $ 532.8 $ 1,057.1 $ 1,011.8 Consumables 493.3 459.9 941.1 881.4 Total net sales $ 1,042.1 $ 992.7 $ 1,998.2 $ 1,893.2
Third Party Net Sales, Excluding Precious Metal Content	Third Party Net Sales, Excluding Precious Metal Content Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 539.4 $ 523.1 $ 1,037.4 $ 991.0 Consumables 493.3 459.9 941.1 881.4 Total net sales, excluding precious metal content 1,032.7 983.0 1,978.5 1,872.4 Precious metal content of sales 9.4 9.7 19.7 20.8 Total net sales, including precious metal content $ 1,042.1 $ 992.7 $ 1,998.2 $ 1,893.2
Segment Adjusted Operating Income	Segment Adjusted Operating Income Three Months Ended Six Months Ended (in millions) 2018 2017 2018 2017 Technologies & Equipment $ 77.1 $ 98.0 $ 151.8 $ 151.9 Consumables 146.0 122.8 253.2 238.9 Segment adjusted operating income before income taxes and interest 223.1 220.8 405.0 390.8 Reconciling items expense (income): All Other (a) 50.5 46.3 101.8 82.3 Goodwill impairment 1,085.8 1,092.9 1,085.8 1,092.9 Restructuring and other costs 188.9 81.7 199.1 84.8 Interest expense 9.6 9.6 18.2 18.9 Interest income (0.4 ) (0.6 ) (1.0 ) (1.3 ) Other expense (income), net (1.0 ) 7.8 (35.1 ) 6.8 Amortization of intangible assets 50.2 46.5 100.1 91.8 Depreciation resulting from the fair value step-up of property, plant and equipment from business combinations 1.8 1.4 3.6 2.8 Loss before income taxes $ (1,162.3 ) $ (1,064.8 ) $ (1,067.5 ) $ (988.2 ) (a) Includes the results of unassigned Corporate headquarter costs, inter-segment eliminations and one distribution warehouse not managed by named segments

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2018
Inventory Disclosure [Abstract]
Inventories, Net	Inventories, net of inventory valuation reserves, consist of the following: (in millions) June 30, 2018 December 31, 2017 Finished goods $ 441.6 $ 387.6 Work-in-process 88.4 90.4 Raw materials and supplies 136.3 145.1 Inventories, net $ 666.3 $ 623.1

BENEFIT PLANS (Tables)

BENEFIT PLANS (Tables)	6 Months Ended
	Jun. 30, 2018
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Components of Net Periodic Benefit Cost	The following sets forth the components of net periodic benefit cost of the Company’s defined benefit plans for the three and six months ended June 30, 2018 and 2017 : Defined Benefit Plans Three Months Ended Six Months Ended Location on Consolidated Statements of Operations (in millions) 2018 2017 (a) 2018 2017 (a) Service cost $ 1.9 $ 2.0 $ 3.7 $ 3.7 Cost of products sold Service cost 2.1 1.9 4.5 4.0 Selling, general and administrative expenses Interest cost 1.9 1.8 3.6 3.5 Other expense (income), net Expected return on plan assets (1.3 ) (1.2 ) (2.7 ) (2.3 ) Other expense (income), net Amortization of prior service credit (0.1 ) (0.1 ) (0.1 ) (0.1 ) Other expense (income), net Amortization of net actuarial loss 1.7 1.7 3.4 3.3 Other expense (income), net Net periodic benefit cost $ 6.2 $ 6.1 $ 12.4 $ 12.1 (a) Prior period presented reflects adoption of ASU 2017-07. For further discussion on the reclassification, refer to Note 1, Significant Accounting Policies.
Information Related to the Contributions to the Company's Benefit Plans	The following sets forth the information related to the contributions to the Company’s defined benefit plans for 2018 : (in millions) Pension Benefits Actual contributions through June 30, 2018 $ 7.7 Expected contributions for the remainder of the year 8.4 Total actual and expected contributions $ 16.1

RESTRUCTURING AND OTHER COSTS (

RESTRUCTURING AND OTHER COSTS (Tables)	6 Months Ended
	Jun. 30, 2018
Restructuring and Related Activities [Abstract]
Restructuring Accruals	At June 30, 2018 , the Company’s restructuring accruals were as follows: Severance (in millions) 2016 and 2017 Plans 2018 Plans Total Balance at December 31, 2017 $ 7.7 $ 48.2 $ — $ 55.9 Provisions 0.7 0.2 10.8 11.7 Amounts applied (1.8 ) (7.7 ) (5.9 ) (15.4 ) Change in estimates (0.1 ) (1.8 ) (0.2 ) (2.1 ) Balance at June 30, 2018 $ 6.5 $ 38.9 $ 4.7 $ 50.1 Lease/Contract Terminations (in millions) 2016 and 2017 Plans Total Balance at December 31, 2017 $ 0.4 $ 0.2 $ 0.6 Provisions 0.3 (0.1 ) 0.2 Amounts applied (0.5 ) (0.1 ) (0.6 ) Balance at June 30, 2018 $ 0.2 $ — $ 0.2 Other Restructuring Costs (in millions) 2016 and 2017 Plans 2018 Plans Total Balance at December 31, 2017 $ 2.1 $ 1.7 $ — $ 3.8 Provisions 0.2 0.4 0.2 0.8 Amounts applied (1.5 ) (0.4 ) (0.2 ) (2.1 ) Balance at June 30, 2018 $ 0.8 $ 1.7 $ — $ 2.5
Cumulative Amounts for the Provisions and Adjustments and Amounts Applied for All the Plans by Segment	The following table provides the year-to-date changes in the restructuring accruals by segment: (in millions) December 31, 2017 Provisions Amounts Applied Change in Estimates June 30, 2018 Technologies & Equipment $ 46.9 $ 7.2 $ (7.9 ) $ (1.8 ) $ 44.4 Consumables 13.3 4.1 (8.2 ) (0.3 ) 8.9 All Other 0.1 1.4 (2.0 ) — (0.5 ) Total $ 60.3 $ 12.7 $ (18.1 ) $ (2.1 ) $ 52.8

FINANCIAL INSTRUMENTS AND DER32

FINANCIAL INSTRUMENTS AND DERIVATIVES (Tables)	6 Months Ended
	Jun. 30, 2018
Derivative [Line Items]
Schedule of Derivative Instruments	The following table summarizes the notional amounts of cash flow hedges by derivative instrument type at June 30, 2018 and the notional amounts expected to mature during the next 12 months, with a discussion of the various cash flow hedges by derivative instrument type following the table: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 301.4 $ 232.7 Interest rate swaps 113.2 — Total derivative instruments designated as cash flow hedges $ 414.6 $ 232.7
Schedule of Aggregate Notional Amounts of Economic Hedges Not Designated as Hedges	The following tables summarize the aggregate notional amounts of the Company’s economic hedges not designated as hedges by derivative instrument types at June 30, 2018 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 388.0 $ 388.0 Total for instruments not designated as hedges $ 388.0 $ 388.0 The following table summarizes the notional amount of hedges of net investments by derivative instrument at June 30, 2018 and the notional amounts expected to mature during the next 12 months: Aggregate Aggregate Notional Amount Maturing within 12 Months (in millions) Foreign exchange forward contracts $ 600.6 $ 299.5 Cross currency basis swaps 286.5 — Total for instruments not designated as hedges $ 887.1 $ 299.5
Derivative Instruments, Gain (Loss)	The following table summarizes the amounts of gains (losses) recorded on the Company’s Consolidated Statements of Operations related to the economic hedges not designated as hedging for the three and six months ended June 30, 2018 and 2017 : Consolidated Statements of Operations Location Gain (Loss) Recognized Three Months Ended (in millions) 2018 2017 Foreign exchange forward contracts (a) Other expense (income), net $ 3.6 $ (2.3 ) Total for instruments not designated as hedges $ 3.6 $ (2.3 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in Other expense (income), net on the Consolidated Statements of Operations. Consolidated Statements of Operations Location Gain (Loss) Recognized Six Months Ended (in millions) 2018 2017 Foreign exchange forward contracts (a) Other expense (income), net $ 4.3 $ (5.1 ) Total for instruments not designated as hedges $ 4.3 $ (5.1 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in Other expense (income), net on the Consolidated Statements of Operations.
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following tables summarize the fair value and the location of the Company’s derivatives on the Consolidated Balance Sheets at June 30, 2018 and December 31, 2017 : June 30, 2018 (in millions) Prepaid Expenses and Other Current Assets, Net Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 11.4 $ 10.4 $ 6.5 $ 1.0 Interest rate swaps — — 0.3 — Cross currency basis swaps — 3.0 — — Total $ 11.4 $ 13.4 $ 6.8 $ 1.0 Not Designated as Hedges Foreign exchange forward contracts $ 2.7 $ — $ 4.3 $ — Total $ 2.7 $ — $ 4.3 $ — December 31, 2017 (in millions) Prepaid Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 1.4 $ — $ 13.4 $ 4.5 Interest rate swaps — — 0.3 0.1 Total $ 1.4 $ — $ 13.7 $ 4.6 Not Designated as Hedges Foreign exchange forward contracts $ 3.4 $ — $ 3.7 $ — Total $ 3.4 $ — $ 3.7 $ —
Offsetting Derivative Assets and Liabilities	Offsetting of financial assets and liabilities under netting arrangements at June 30, 2018 : Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 24.9 $ — $ 24.9 $ (9.5 ) $ — $ 15.4 Cross currency basis swaps 3.0 — 3.0 (2.7 ) — 0.3 Total Assets $ 27.9 $ — $ 27.9 $ (12.2 ) $ — $ 15.7 Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 12.2 $ — $ 12.2 $ (12.0 ) $ — $ 0.2 Interest rate swaps 0.3 — 0.3 (0.2 ) — 0.1 Total Liabilities $ 12.5 $ — $ 12.5 $ (12.2 ) $ — $ 0.3 Offsetting of financial assets and liabilities under netting arrangements at December 31, 2017 : Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 4.8 $ — $ 4.8 $ (3.9 ) $ — $ 0.9 Total Assets $ 4.8 $ — $ 4.8 $ (3.9 ) $ — $ 0.9 Gross Amounts Not Offset on the Consolidated Balance Sheets (in millions) Gross Amounts Recognized Gross Amount Offset on the Consolidated Balance Sheets Net Amounts Presented on the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 21.6 $ — $ 21.6 $ (3.8 ) $ — $ 17.8 Interest rate swaps 0.4 — 0.4 (0.1 ) — 0.3 Total Liabilities $ 22.0 $ — $ 22.0 $ (3.9 ) $ — $ 18.1
Cash Flow Hedging
Derivative [Line Items]
Schedule of Derivative Instruments	The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to all cash flow hedges for the three months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ — Interest expense $ (0.6 ) $ — Foreign exchange forward contracts 2.8 Cost of products sold (4.2 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.3 ) Total in cash flow hedging $ 2.8 $ (4.8 ) $ (0.3 ) June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ (0.2 ) Interest expense $ (0.4 ) $ — Foreign exchange forward contracts (1.2 ) Cost of products sold 0.5 — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.2 ) Total for cash flow hedging $ (1.4 ) $ 0.1 $ (0.2 ) The following tables summarize the amount of gain (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to all cash flow hedges for the six months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ (0.1 ) Interest expense $ (1.1 ) $ — Foreign exchange forward contracts (4.1 ) Cost of products sold (6.1 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.4 ) Total in cash flow hedging $ (4.2 ) $ (7.2 ) $ (0.4 ) June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in millions) Effective Portion: Interest rate swaps $ — Interest expense $ (1.1 ) $ — Foreign exchange forward contracts (2.7 ) Cost of products sold 1.0 — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (0.5 ) Total for cash flow hedging $ (2.7 ) $ (0.1 ) $ (0.5 )
Net Investment Hedging
Derivative [Line Items]
Schedule of Derivative Instruments	The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and Other expense (income), net on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the three months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Cross currency basis swaps $ 16.0 Interest expense $ 1.9 Foreign exchange forward contracts 31.3 Other expense (income), net 3.9 Total for net investment hedging $ 47.3 $ 5.8 June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Foreign exchange forward contracts $ (2.4 ) Other expense (income), net $ 0.3 Total for net investment hedging $ (2.4 ) $ 0.3 The following tables summarize the amount of gain (losses) recorded in AOCI on the Consolidated Balance Sheets and income (expense) on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the six months ended June 30, 2018 and 2017 : June 30, 2018 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Cross currency basis swaps $ 9.6 Interest expense $ 3.6 Other expense (income), net (6.6 ) Foreign exchange forward contracts 19.8 Other expense (income), net 5.4 Total for net investment hedging $ 29.4 $ 2.4 June 30, 2017 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in millions) Effective Portion: Foreign exchange forward contracts $ (4.2 ) Other expense (income), net $ 0.8 Total for net investment hedging $ (4.2 ) $ 0.8

FAIR VALUE MEASUREMENT (Tables)

FAIR VALUE MEASUREMENT (Tables)	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities that are Recorded at Fair Value and Classified Based on the Lowest Level of Input	The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at June 30, 2018 and December 31, 2017 : June 30, 2018 (in millions) Total Level 1 Level 2 Level 3 Assets Cross currency basis swaps $ 3.0 $ — $ 3.0 $ — Foreign exchange forward contracts 24.5 — 24.5 — Total assets $ 27.5 $ — $ 27.5 $ — Liabilities Interest rate swaps $ 0.3 $ — $ 0.3 $ — Foreign exchange forward contracts 11.8 — 11.8 — Contingent considerations on acquisitions 8.8 — — 8.8 Total liabilities $ 20.9 $ — $ 12.1 $ 8.8 December 31, 2017 (in millions) Total Level 1 Level 2 Level 3 Assets Foreign exchange forward contracts $ 4.8 $ — $ 4.8 $ — Available-for-sale security 54.4 — 54.4 — Total assets $ 59.2 $ — $ 59.2 $ — Liabilities Interest rate swaps $ 0.4 $ — $ 0.4 $ — Foreign exchange forward contracts 21.6 — 21.6 — Contingent considerations on acquisitions 8.6 — — 8.6 Total liabilities $ 30.6 $ — $ 22.0 $ 8.6
Reconciliation of Level 3 Holdings Measured at Fair Value on a Recurring Basis Using Unobservable Inputs	The following table presents a reconciliation of the Company’s Level 3 holdings measured at fair value on a recurring basis using unobservable inputs: Earn-out (in millions) Obligations Balance at December 31, 2017 $ 8.6 Fair value adjustment: Reported in Other expense (income), net 0.4 Effect of exchange rate changes (0.2 ) Balance at June 30, 2018 $ 8.8

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Goodwill	reconciliation of changes in the Company’s goodwill by reportable segment is as follows: (in millions) Technologies & Equipment Consumables Total Balance at December 31, 2017 $ 3,660.6 $ 878.6 $ 4,539.2 Acquisition related additions — 66.5 66.5 Measurement period adjustments on prior acquisitions — 0.5 0.5 Impairment (1,017.2 ) (68.5 ) (1,085.7 ) Effects of exchange rate changes (51.3 ) (11.4 ) (62.7 ) Balance at June 30, 2018 $ 2,592.1 $ 865.7 $ 3,457.8 The following table provides the gross carrying amount of goodwill and the cumulative goodwill impairment: June 30, 2018 December 31, 2017 (in millions) Gross Carrying Amount Cumulative Impairment Net Carrying Amount Gross Carrying Amount Cumulative Impairment Net Carrying Amount Technologies & Equipment $ 5,260.2 $ (2,668.1 ) $ 2,592.1 $ 5,311.5 $ (1,650.9 ) $ 3,660.6 Consumables 934.2 (68.5 ) 865.7 878.6 — 878.6 Total effect of cumulative impairment 6,194.4 (2,736.6 ) 3,457.8 6,190.1 (1,650.9 ) 4,539.2 I
Schedule of Definite-lived and Indefinite-lived Intangible Assets	entifiable definite-lived and indefinite-lived intangible assets consist of the following: June 30, 2018 December 31, 2017 (in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Patents and developed technology $ 1,416.1 $ (353.5 ) $ 1,062.6 $ 1,385.5 $ (305.0 ) $ 1,080.5 Trademarks 82.6 (61.5 ) 21.1 76.4 (46.5 ) 29.9 Licensing agreements 36.1 (25.4 ) 10.7 31.2 (24.8 ) 6.4 Customer relationships 1,098.8 (301.8 ) 797.0 1,109.1 (272.0 ) 837.1 Total definite-lived $ 2,633.6 $ (742.2 ) $ 1,891.4 $ 2,602.2 $ (648.3 ) $ 1,953.9 Indefinite-lived tradenames and trademarks $ 655.4 $ — $ 655.4 $ 846.8 $ — $ 846.8 Total identifiable intangible assets $ 3,289.0 $ (742.2 ) $ 2,546.8 $ 3,449.0 $ (648.3 ) $ 2,800.7

SIGNIFICANT ACCOUNTING POLICI35

SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Jun. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Significant Accounting Policies [Line Items]
Deferred revenue		$ 26.2
Reclassification on adoption of ASU				$ (0.5)
ASU 2018-02
Significant Accounting Policies [Line Items]
Reclassification on adoption of ASU			$ 8.1
AOCI including portion attributable to noncontrolling interest | ASU 2018-02
Significant Accounting Policies [Line Items]
Reclassification on adoption of ASU			(8.1)
Retained Earnings
Significant Accounting Policies [Line Items]
Reclassification on adoption of ASU				$ (1.5)
Retained Earnings | ASU 2018-02
Significant Accounting Policies [Line Items]
Reclassification on adoption of ASU			8.1
DIO Corporation
Significant Accounting Policies [Line Items]
Proceeds from sale of direct investment	$ 54.1
Gain realized on cost-method investment	$ 44.1
Unrealized gain in accumulated other comprehensive income			45
Fair value of direct investment			54.4
Trade Accounts Receivable
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts and trade discounts		$ 23.4	$ 22.4

SIGNIFICANT ACCOUNTING POLICI36

SIGNIFICANT ACCOUNTING POLICIES - ACCOUNTING ADJUSTMENTS (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jan. 01, 2018	Dec. 31, 2017
Assets
Accounts and notes receivables-trade, net	$ 710.3		$ 710.3			$ 746.2
Inventories, net	666.3		666.3			623.1
Prepaid expenses and other current assets, net	276.5		276.5			312.6
Other noncurrent assets, net	67.4		67.4			156.1
Liabilities and Equity
Accrued liabilities	575.3		575.3			585.8
Income taxes payable	31.9		31.9			54.2
Deferred income taxes	538		538			718
Retained earnings	1,216.2		1,216.2			2,316.2
Income Statement
Net sales	1,042.1	$ 992.7	1,998.2	$ 1,893.2
Cost of products sold	489.3	448.5	931.3	857
Selling, general and administrative expenses	432.2	417.6	867.4	822.3
Provision (benefit) for income taxes	(41.3)	(14.5)	(27.6)	2.4
Net loss attributable to Dentsply Sirona	(1,122)	(1,050)	(1,040.8)	(990.2)
Gross profit	552.8	544.2	1,066.9	1,036.2
Operating loss	(1,154.1)	(1,048)	(1,085.4)	(963.8)
Other expense (income), net	(1)	7.8	(35.1)	6.8
Balances Without Adoption of ASC 606
Assets
Accounts and notes receivables-trade, net	710.2		710.2			746.2
Inventories, net	666.6		666.6			623.1
Prepaid expenses and other current assets, net	273.4		273.4			312.6
Liabilities and Equity
Accrued liabilities	563.4		563.4			585.8
Income taxes payable	34.2		34.2			54.2
Retained earnings	1,222.9		1,222.9			$ 2,316.2
Income Statement
Net sales	1,044.8		1,998.8
Cost of products sold	491.4		930.3
Selling, general and administrative expenses	432.3		868.1
Provision (benefit) for income taxes	(41.2)		(27.4)
Net loss attributable to Dentsply Sirona	(1,121.6)		(1,040.1)
Revised
Income Statement
Cost of products sold		448.2		856.2
Selling, general and administrative expenses		415.7		818.7
Gross profit		544.5		1,037
Operating loss		(1,045.8)		(959.4)
Other expense (income), net		10		11.2
Accounting Standards Update 2014-09
Assets
Accounts and notes receivables-trade, net					$ 746.4
Inventories, net					622.8
Prepaid expenses and other current assets, net					314.5
Liabilities and Equity
Accrued liabilities					595.7
Income taxes payable					52.1
Retained earnings					2,310.2
Accounting Standards Update 2014-09 | Effect of Change Increase/(Decrease)
Assets
Accounts and notes receivables-trade, net	0.1		0.1		0.2
Inventories, net	(0.3)		(0.3)		(0.3)
Prepaid expenses and other current assets, net	3.1		3.1		1.9
Liabilities and Equity
Accrued liabilities	11.9		11.9		9.9
Income taxes payable	(2.3)		(2.3)		(2.1)
Retained earnings	(6.7)		(6.7)		(6)
Income Statement
Net sales	(2.7)		(0.6)
Cost of products sold	(2.1)		1
Selling, general and administrative expenses	(0.1)		(0.7)
Provision (benefit) for income taxes	(0.1)		(0.2)
Net loss attributable to Dentsply Sirona	$ (0.4)		$ (0.7)
Accounting Standards Update 2016-16
Assets
Prepaid expenses and other current assets, net					307
Other noncurrent assets, net					83
Liabilities and Equity
Deferred income taxes					642
Retained earnings					2,313.5
Accounting Standards Update 2016-16 | Classification Adjustment As Revised
Assets
Prepaid expenses and other current assets, net					(5.6)
Other noncurrent assets, net					(73.1)
Liabilities and Equity
Deferred income taxes					(76)
Retained earnings					$ (2.7)
Accounting Standards Update 2017-07 | Classification Adjustment As Revised
Income Statement
Cost of products sold		(0.3)		(0.8)
Selling, general and administrative expenses		(1.9)		(3.6)
Gross profit		0.3		0.8
Operating loss		2.2		4.4
Other expense (income), net		$ 2.2		$ 4.4

STOCK COMPENSATION (Details)

STOCK COMPENSATION (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 0.1	$ 10.5	$ 9.3	$ 20.9
Related deferred income tax benefit	0	2.5	1.6	5.8
Selling, general and administrative expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	1.2	10.3	8.3	20.4
Cost of Products Sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	0.1	0.2	0.4	0.5
Restructuring and Other Costs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	1.2		0.5
Stock option expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	2.7	2.5	3.4	5.2
RSU expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ (2.6)	$ 8	$ 5.9	$ 15.7

COMPREHENSIVE INCOME (LOSS) - S

COMPREHENSIVE INCOME (LOSS) - SUMMARY OF COMPREHENSIVE INCOME, NET OF TAX (Details) - Foreign Currency Translation Gain (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Condensed Statement of Income Captions [Line Items]
Foreign currency translation gains	$ 0	$ 248.2	$ 0	$ 304.8
Foreign currency translation losses	(223.4)	0	(139.4)	0
Net Investment Hedging
Condensed Statement of Income Captions [Line Items]
Foreign currency translation gains	31	0	12.1	0
Foreign currency translation losses	$ 0	$ (24.2)	$ 0	$ (33.6)

COMPREHENSIVE INCOME (LOSS) - A

COMPREHENSIVE INCOME (LOSS) - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Derivative [Line Items]
Cumulative foreign currency translation adjustment gain (loss)	$ 5,140.1	$ 6,627.9	$ 7,274.2	$ 8,125.9
Foreign Currency Translation Gain (Loss)
Derivative [Line Items]
Foreign currency tax adjustment	168.5	203.8
Cumulative foreign currency translation adjustment gain (loss)	(231.8)	(104.5)	$ (219.3)	$ (490.5)
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest, Translation Gain (Loss)
Derivative [Line Items]
Cumulative foreign currency translation adjustment gain (loss)	(117.3)	22.1
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest, Net Investment Hedges
Derivative [Line Items]
Cumulative foreign currency translation adjustment gain (loss)	$ (114.5)	$ (126.6)

COMPREHENSIVE INCOME (LOSS) - B

COMPREHENSIVE INCOME (LOSS) - BALANCES INCLUDED IN AOCI, NET OF TAX, IN THE CONSOLIDATED BALANCE SHEETS (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			$ 6,627.9	$ 8,125.9
Total other comprehensive (loss) income, net of tax	$ (160)	$ 220.6	(149.4)	268.2
Ending Balance	5,140.1	7,274.2	5,140.1	7,274.2
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			(291)	(705.7)
Other comprehensive (loss) income before reclassifications and tax impact			(79)	238.9
Tax (expense) benefit			(35.3)	26.4
Other comprehensive (loss) income, net of tax, before reclassifications			(114.3)	265.3
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			(35.5)	2.4
Total other comprehensive (loss) income, net of tax			(149.8)	267.7
Ending Balance	(440.8)	(438)	(440.8)	(438)
Foreign Currency Translation Gain (Loss)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			(104.5)	(490.5)
Other comprehensive (loss) income before reclassifications and tax impact			(106.6)	245.8
Tax (expense) benefit			(20.7)	25.4
Other comprehensive (loss) income, net of tax, before reclassifications			(127.3)	271.2
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			0	0
Total other comprehensive (loss) income, net of tax			(127.3)	271.2
Ending Balance	(231.8)	(219.3)	(231.8)	(219.3)
Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			(12.6)	(3.2)
Other comprehensive (loss) income before reclassifications and tax impact			(4.2)	(2.7)
Tax (expense) benefit			0.5	0.2
Other comprehensive (loss) income, net of tax, before reclassifications			(3.7)	(2.5)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			6.4	0.1
Total other comprehensive (loss) income, net of tax			2.7	(2.4)
Ending Balance	(9.9)	(5.6)	(9.9)	(5.6)
Gain and (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			(127.6)	(116.8)
Other comprehensive (loss) income before reclassifications and tax impact			29.4	(4.2)
Tax (expense) benefit			(14.5)	0.8
Other comprehensive (loss) income, net of tax, before reclassifications			14.9	(3.4)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			0	0
Total other comprehensive (loss) income, net of tax			14.9	(3.4)
Ending Balance	(112.7)	(120.2)	(112.7)	(120.2)
Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			44.3
Other comprehensive (loss) income before reclassifications and tax impact			0
Other comprehensive (loss) income, net of tax, before reclassifications			0
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			(44.3)
Total other comprehensive (loss) income, net of tax			(44.3)
Ending Balance	0		0
Pension Liability Gain (Loss)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning Balance			(90.6)	(95.2)
Other comprehensive (loss) income before reclassifications and tax impact			2.4	0
Tax (expense) benefit			(0.6)	0
Other comprehensive (loss) income, net of tax, before reclassifications			1.8	0
Amounts reclassified from accumulated other comprehensive income (loss), net of tax			2.4	2.3
Total other comprehensive (loss) income, net of tax			4.2	2.3
Ending Balance	$ (86.4)	$ (92.9)	$ (86.4)	$ (92.9)

COMPREHENSIVE INCOME (LOSS) - R

COMPREHENSIVE INCOME (LOSS) - RECLASSIFICATION OUT OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Interest expense	$ (9.6)	$ (9.6)	$ (18.2)	$ (18.9)
Cost of products sold	(489.3)	(448.5)	(931.3)	(857)
Net (loss) gain before tax	(1,162.3)	(1,064.8)	(1,067.5)	(988.2)
Provision (benefit) for income taxes	(41.3)	(14.5)	(27.6)	2.4
Other expense (income), net	1	(7.8)	35.1	(6.8)
Net loss	(1,121)	(1,050.3)	(1,039.9)	(990.6)
Net realized holding gain on available-for-sale securities:
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Reclassification net, gain (loss) after tax			44.3
Amortization of prior service benefits
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Amortization of defined benefit pension and other postemployment benefit items	0	0.1	0	0.1
Reclassification out of Accumulated Other Comprehensive Income
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Reclassification net, gain (loss) after tax	(5.3)	(1)	35.5	(2.4)
Reclassification out of Accumulated Other Comprehensive Income | Gain and (loss) on derivative financial instruments
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Net (loss) gain before tax	(4.8)	0.1	(7.2)	(0.1)
Provision (benefit) for income taxes	(0.7)	0	0.8	0
Net loss	(4.1)	0.1	(6.4)	(0.1)
Reclassification out of Accumulated Other Comprehensive Income | Gain and (loss) on derivative financial instruments | Interest rate swaps
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Interest expense	(0.5)	(0.4)	(1.1)	(1.1)
Reclassification out of Accumulated Other Comprehensive Income | Gain and (loss) on derivative financial instruments | Foreign exchange forward contracts
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Cost of products sold	(4.3)	0.5	(6.1)	1
Reclassification out of Accumulated Other Comprehensive Income | Net realized holding gain on available-for-sale securities:
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Provision (benefit) for income taxes			(0.7)	0
Other expense (income), net			45	0
Net loss			44.3	0
Reclassification out of Accumulated Other Comprehensive Income | Pension Liability Gain (Loss)
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Amortization of defined benefit pension and other postemployment benefit items	(1.7)	(1.6)	(3.4)	(3.3)
Provision (benefit) for income taxes	0.5	0.5	1	1
Reclassification net, gain (loss) after tax	(1.2)	(1.1)	(2.4)	(2.3)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of net actuarial losses
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Amortization of defined benefit pension and other postemployment benefit items	$ (1.7)	$ (1.7)	$ (3.4)	$ (3.4)

EARNINGS PER COMMON SHARE - ADD

EARNINGS PER COMMON SHARE - ADDITIONAL INFORMATION (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Earnings Per Share [Abstract]
Antidilutive common stock options not included in the computation of diluted earnings per common share (in shares)	5.5	0.8	4.7	1.2

BUSINESS COMBINATIONS - SUMMARY

BUSINESS COMBINATIONS - SUMMARY OF INTANGIBLE ASSETS (Details) - USD ($) $ in Millions	May 01, 2018	Jun. 30, 2017	Jun. 30, 2018	Dec. 31, 2017
Acquired Finite-Lived Intangible Assets [Line Items]
Identifiable intangible assets, net			$ 2,546.8	$ 2,800.7
OraMetrix, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Identifiable intangible assets, net	$ 93.7
OraMetrix, Inc. | Trade names and trademarks
Acquired Indefinite-lived Intangible Assets [Line Items]
Intangible assets acquired, amount	12.8
OraMetrix, Inc. | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets acquired, amount	$ 17.5
Intangible assets acquired, useful life (in years)	15 years
OraMetrix, Inc. | Developed technology and patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets acquired, amount	$ 63.4
Intangible assets acquired, useful life (in years)	15 years
RTD
Acquired Finite-Lived Intangible Assets [Line Items]
Identifiable intangible assets, net		$ 49
RTD | Trade names and trademarks
Acquired Indefinite-lived Intangible Assets [Line Items]
Intangible assets acquired, amount		8.5
RTD | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets acquired, amount		$ 18.1
Intangible assets acquired, useful life (in years)		15 years
RTD | Developed technology and patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets acquired, amount		$ 22.4
Intangible assets acquired, useful life (in years)		15 years

BUSINESS COMBINATIONS - ADDITIO

BUSINESS COMBINATIONS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	May 01, 2018	Jun. 30, 2017	Jun. 30, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Goodwill			$ 3,457.8	$ 4,539.2
OraMetrix, Inc.
Business Acquisition [Line Items]
Consideration transferred	$ 120
Additional payments subject to meeting earn-out provisions	$ 30
Goodwill			$ 62.8
RTD
Business Acquisition [Line Items]
Consideration transferred		$ 132
Goodwill		$ 83.9

SEGMENT INFORMATION - ADDITIONA

SEGMENT INFORMATION - ADDITIONAL INFORMATION (Details) - segment	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting Information [Line Items]
Number of operating groups			2
Dental Products
Segment Reporting Information [Line Items]
Percentage of sales, professional dental products	92.00%	92.00%	92.00%	92.00%

SEGMENT INFORMATION - THIRD PAR

SEGMENT INFORMATION - THIRD PARTY NET SALES (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenue, Major Customer [Line Items]
Net sales	$ 1,042.1	$ 992.7	$ 1,998.2	$ 1,893.2
Technologies & Equipment
Revenue, Major Customer [Line Items]
Net sales	548.8	532.8	1,057.1	1,011.8
Consumables
Revenue, Major Customer [Line Items]
Net sales	$ 493.3	$ 459.9	$ 941.1	$ 881.4

SEGMENT INFORMATION - THIRD P47

SEGMENT INFORMATION - THIRD PARTY NET SALES, EXCLUDING PRECIOUS METAL CONTENT (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenue, Major Customer [Line Items]
Net sales	$ 1,042.1	$ 992.7	$ 1,998.2	$ 1,893.2
Technologies & Equipment
Revenue, Major Customer [Line Items]
Net sales	548.8	532.8	1,057.1	1,011.8
Consumables
Revenue, Major Customer [Line Items]
Net sales	493.3	459.9	941.1	881.4
Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,032.7	983	1,978.5	1,872.4
Operating Segments | Technologies & Equipment
Revenue, Major Customer [Line Items]
Net sales	539.4	523.1	1,037.4	991
Operating Segments | Consumables
Revenue, Major Customer [Line Items]
Net sales	493.3	459.9	941.1	881.4
Segment Reconciling Items
Revenue, Major Customer [Line Items]
Net sales	$ 9.4	$ 9.7	$ 19.7	$ 20.8

SEGMENT INFORMATION - SEGMENT A

SEGMENT INFORMATION - SEGMENT ADJUSTED OPERATING INCOME (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income	$ (1,154.1)	$ (1,048)	$ (1,085.4)	$ (963.8)
Goodwill impairment	1,085.8	1,092.9	1,085.8	1,092.9
Restructuring and other costs	188.9	81.7	199.1	84.8
Interest expense	9.6	9.6	18.2	18.9
Interest income	(0.4)	(0.6)	(1)	(1.3)
Other expense (income), net	(1)	7.8	(35.1)	6.8
Amortization of intangible assets			100.1	91.8
Loss before income taxes	(1,162.3)	(1,064.8)	(1,067.5)	(988.2)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income	223.1	220.8	405	390.8
Operating Segments | Technologies & Equipment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income	77.1	98	151.8	151.9
Operating Segments | Consumables
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income	146	122.8	253.2	238.9
All Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
All Other	50.5	46.3	101.8	82.3
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Goodwill impairment	1,085.8	1,092.9	1,085.8	1,092.9
Restructuring and other costs	188.9	81.7	199.1	84.8
Interest expense	9.6	9.6	18.2	18.9
Interest income	(0.4)	(0.6)	(1)	(1.3)
Other expense (income), net	(1)	7.8	(35.1)	6.8
Amortization of intangible assets	50.2	46.5	100.1	91.8
Depreciation resulting from the fair value step-up of property, plant and equipment from business combinations	$ 1.8	$ 1.4	$ 3.6	$ 2.8

INVENTORIES - ADDITIONAL INFORM

INVENTORIES - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
LIFO inventory amount	$ 12.7	$ 12.4
Inventory, LIFO reserve	8.8	10.6
Inventory valuation reserve	$ 75.1	$ 71.7

INVENTORIES - SUMMARY OF INVENT

INVENTORIES - SUMMARY OF INVENTORY (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Finished goods	$ 441.6	$ 387.6
Work-in-process	88.4	90.4
Raw materials and supplies	136.3	145.1
Inventories, net	$ 666.3	$ 623.1

BENEFIT PLANS - COMPONENTS OF N

BENEFIT PLANS - COMPONENTS OF NET PERIODIC BENEFIT COST (Details) - Defined Benefit Plans - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	$ 6.2	$ 6.1	$ 12.4	$ 12.1
Cost of products sold
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	1.9	2	3.7	3.7
Selling, general and administrative expenses
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	2.1	1.9	4.5	4
Other expense (income), net
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Interest cost	1.9	1.8	3.6	3.5
Expected return on plan assets	(1.3)	(1.2)	(2.7)	(2.3)
Amortization of prior service credit	(0.1)	(0.1)	(0.1)	(0.1)
Amortization of net actuarial loss	$ 1.7	$ 1.7	$ 3.4	$ 3.3

BENEFIT PLANS - INFORMATION REL

BENEFIT PLANS - INFORMATION RELATED TO THE CONTRIBUTIONS TO THE COMPANY'S BENEFIT PLANS (Details) - Defined Benefit Plans $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actual contributions through June 30, 2018	$ 7.7
Expected contributions for the remainder of the year	8.4
Total actual and expected contributions	$ 16.1

RESTRUCTURING AND OTHER COSTS -

RESTRUCTURING AND OTHER COSTS - RESTRUCTURING ACCURALS (Details) $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 60.3
Provisions	12.7
Amounts applied	(18.1)
Change in estimates	(2.1)
Ending Balance	52.8
Severance
Restructuring Reserve [Roll Forward]
Beginning Balance	55.9
Provisions	11.7
Amounts applied	(15.4)
Change in estimates	(2.1)
Ending Balance	50.1
Severance | 2016 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	7.7
Provisions	0.7
Amounts applied	(1.8)
Change in estimates	(0.1)
Ending Balance	6.5
Severance | 2017 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	48.2
Provisions	0.2
Amounts applied	(7.7)
Change in estimates	(1.8)
Ending Balance	38.9
Severance | 2018 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0
Provisions	10.8
Amounts applied	(5.9)
Change in estimates	(0.2)
Ending Balance	4.7
Lease/Contract Terminations
Restructuring Reserve [Roll Forward]
Beginning Balance	0.6
Provisions	0.2
Amounts applied	(0.6)
Ending Balance	0.2
Lease/Contract Terminations | 2016 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0.4
Provisions	0.3
Amounts applied	(0.5)
Ending Balance	0.2
Lease/Contract Terminations | 2017 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0.2
Provisions	(0.1)
Amounts applied	(0.1)
Ending Balance	0
Other Restructuring Costs
Restructuring Reserve [Roll Forward]
Beginning Balance	3.8
Provisions	0.8
Amounts applied	(2.1)
Ending Balance	2.5
Other Restructuring Costs | 2016 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	2.1
Provisions	0.2
Amounts applied	(1.5)
Ending Balance	0.8
Other Restructuring Costs | 2017 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	1.7
Provisions	0.4
Amounts applied	(0.4)
Ending Balance	1.7
Other Restructuring Costs | 2018 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0
Provisions	0.2
Amounts applied	(0.2)
Ending Balance	$ 0

RESTRUCTURING AND OTHER COSTS54

RESTRUCTURING AND OTHER COSTS - PROVISIONS AND ADJUSTMENTS AND AMOUNTS APPLIED FOR ALL PLANS BY SEGMENT (Details) $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 60.3
Provisions	12.7
Amounts applied	(18.1)
Change in estimates	(2.1)
Ending Balance	52.8
Operating Segments | Technologies & Equipment
Restructuring Reserve [Roll Forward]
Beginning Balance	46.9
Provisions	7.2
Amounts applied	(7.9)
Change in estimates	(1.8)
Ending Balance	44.4
Operating Segments | Consumables
Restructuring Reserve [Roll Forward]
Beginning Balance	13.3
Provisions	4.1
Amounts applied	(8.2)
Change in estimates	(0.3)
Ending Balance	8.9
All Other
Restructuring Reserve [Roll Forward]
Beginning Balance	0.1
Provisions	1.4
Amounts applied	(2)
Change in estimates	0
Ending Balance	$ (0.5)

RESTRUCTURING AND OTHER COSTS55

RESTRUCTURING AND OTHER COSTS - ADDITIONAL INFORMATION (Details) $ in Millions	Apr. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)unit	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring, incurred cost		$ 188.9	$ 81.7	$ 199.1	$ 84.8
Indefinite-lived intangible asset impairment	$ 179.2		$ 79.8	179.2	79.8
Number of reporting units with impairment | unit			2
Net restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring, incurred cost		3.4	$ 1.5	10.8	3.8
Other Restructuring Costs
Restructuring Cost and Reserve [Line Items]
Restructuring, incurred cost		$ 185.5	$ 80.2	$ 188.3	$ 81

FINANCIAL INSTRUMENTS AND DER56

FINANCIAL INSTRUMENTS AND DERIVATIVES - CASH FLOW HEDGES (Details) - Designated as Hedging Instrument $ in Millions	Jun. 30, 2018USD ($)
Derivative [Line Items]
Aggregate Notional Amount	$ 887.1
Aggregate Notional Amount Maturing within 12 Months	299.5
Cash Flow Hedging
Derivative [Line Items]
Aggregate Notional Amount	414.6
Aggregate Notional Amount Maturing within 12 Months	232.7
Cash Flow Hedging | Foreign exchange forward contracts
Derivative [Line Items]
Aggregate Notional Amount	301.4
Aggregate Notional Amount Maturing within 12 Months	232.7
Cash Flow Hedging | Interest rate swaps
Derivative [Line Items]
Aggregate Notional Amount	113.2
Aggregate Notional Amount Maturing within 12 Months	$ 0

FINANCIAL INSTRUMENTS AND DER57

FINANCIAL INSTRUMENTS AND DERIVATIVES - ADDITIONAL INFORMATION (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2018JPY (¥)	Jan. 02, 2018EUR (€)	Dec. 31, 2017USD ($)
Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	$ 887.1		$ 887.1
Not Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	388		388
Cross currency basis swaps | Designated as Hedging Instrument
Derivative [Line Items]
Unrealized gain (loss) on derivatives before tax			(6.5)
Foreign exchange forward contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	388		388
Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	414.6		414.6
Unrealized gain (loss) on derivatives before tax	2.8	$ (1.4)	(4.2)	$ (2.7)
Cash Flow Hedging | Interest rate swaps | Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	113.2		113.2
Net Investment Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Unrealized gain (loss) on derivatives before tax	47.3	$ (2.4)	29.4	$ (4.2)
Net Investment Hedging | Interest rate swaps | Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount | €						€ 245,600,000
Net Investment Hedging | Cross currency basis swaps | Designated as Hedging Instrument
Derivative [Line Items]
Aggregate Notional Amount	$ 286.5		$ 286.5
Term Loan Agreement
Derivative [Line Items]
Aggregate Notional Amount | ¥					¥ 12,600,000,000
Term Loan Agreement | Cash Flow Hedging | Interest rate swaps
Derivative [Line Items]
Derivative, fixed interest rate	0.90%		0.90%		0.90%
Derivative, contract term (in years)			5 years
Fixed Rate Senior Notes | Fixed Rate Senior Notes Due August 2021
Derivative [Line Items]
Long-term debt							$ 295.7
Long-term debt, percentage bearing fixed interest						1.70%	4.10%

FINANCIAL INSTRUMENTS AND DER58

FINANCIAL INSTRUMENTS AND DERIVATIVES - GAIN (LOSS) ON AOCI - CASH FLOW HEDGES (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Derivative [Line Items]
Gain (Loss) in AOCI	$ 2.8	$ (1.4)	$ (4.2)	$ (2.7)
Effective Portion Reclassified from AOCI into Income (Expense)	(4.8)	0.1	(7.2)	(0.1)
Ineffective Portion Recognized in Income (Expense)	(0.3)	(0.2)	(0.4)	(0.5)
Interest Expense | Interest rate swaps
Derivative [Line Items]
Gain (Loss) in AOCI	0	(0.2)	(0.1)	0
Effective Portion Reclassified from AOCI into Income (Expense)	(0.6)	(0.4)	(1.1)	(1.1)
Cost of Products Sold | Foreign exchange forward contracts
Derivative [Line Items]
Gain (Loss) in AOCI	2.8	(1.2)	(4.1)	(2.7)
Effective Portion Reclassified from AOCI into Income (Expense)	(4.2)	0.5	(6.1)	1
Other expense (income), net | Foreign exchange forward contracts
Derivative [Line Items]
Ineffective Portion Recognized in Income (Expense)	$ (0.3)	$ (0.2)	$ (0.4)	$ (0.5)

FINANCIAL INSTRUMENTS AND DER59

FINANCIAL INSTRUMENTS AND DERIVATIVES - NET INVESTMENT HEDGES (Details) - Designated as Hedging Instrument $ in Millions	Jun. 30, 2018USD ($)
Derivative [Line Items]
Aggregate Notional Amount	$ 887.1
Aggregate Notional Amount Maturing within 12 Months	299.5
Net Investment Hedging | Foreign exchange forward contracts
Derivative [Line Items]
Aggregate Notional Amount	600.6
Aggregate Notional Amount Maturing within 12 Months	299.5
Net Investment Hedging | Cross currency basis swaps
Derivative [Line Items]
Aggregate Notional Amount	286.5
Aggregate Notional Amount Maturing within 12 Months	$ 0

FINANCIAL INSTRUMENTS AND DER60

FINANCIAL INSTRUMENTS AND DERIVATIVES - GAIN (LOSS) ON AOCI - NET INVESTMENT HEDGES (Details) - Designated as Hedging Instrument - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Cross currency basis swaps
Derivative [Line Items]
Gain (Loss) in AOCI			$ (6.5)
Net Investment Hedging
Derivative [Line Items]
Gain (Loss) in AOCI	$ 47.3	$ (2.4)	29.4	$ (4.2)
Derivative, gain (loss) recognized in income (expense)	5.8	0.3	2.4	0.8
Net Investment Hedging | Cross currency basis swaps | Interest Income
Derivative [Line Items]
Gain (Loss) in AOCI	16		9.6
Derivative, gain (loss) recognized in income (expense)	1.9		3.6
Net Investment Hedging | Cross currency basis swaps | Other expense (income), net
Derivative [Line Items]
Derivative, gain (loss) recognized in income (expense)			(6.6)
Net Investment Hedging | Foreign exchange forward contracts | Other expense (income), net
Derivative [Line Items]
Gain (Loss) in AOCI	31.3	(2.4)	19.8	(4.2)
Derivative, gain (loss) recognized in income (expense)	$ 3.9	$ 0.3	$ 5.4	$ 0.8

FINANCIAL INSTRUMENTS AND DER61

FINANCIAL INSTRUMENTS AND DERIVATIVES - HEDGES NOT DESIGNATED (Details) - Not Designated as Hedging Instrument - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Derivative [Line Items]
Aggregate Notional Amount	$ 388		$ 388
Aggregate Notional Amount Maturing within 12 Months	388		388
Derivative, gain (loss) recognized in income (expense)	3.6	$ (2.3)	4.3	$ (5.1)
Foreign exchange forward contracts
Derivative [Line Items]
Aggregate Notional Amount	388		388
Aggregate Notional Amount Maturing within 12 Months	388		388
Foreign exchange forward contracts | Other expense (income), net
Derivative [Line Items]
Derivative, gain (loss) recognized in income (expense)	$ 3.6	$ (2.3)	$ 4.3	$ (5.1)

FINANCIAL INSTRUMENTS AND DER62

FINANCIAL INSTRUMENTS AND DERIVATIVES - BALANCE SHEET LOCATION (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Derivative [Line Items]
Derivative asset, fair value, gross	$ 27.9	$ 4.8
Derivative liability, fair value, gross	12.5	22
Prepaid Expenses and Other Current Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	11.4	1.4
Not designated derivative assets, fair value	2.7	3.4
Other Noncurrent Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	13.4	0
Not designated derivative assets, fair value	0	0
Accrued Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	6.8	13.7
Not designated derivative liabilities, fair value	4.3	3.7
Other Noncurrent Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	1	4.6
Not designated derivative liabilities, fair value	0	0
Foreign exchange forward contracts | Prepaid Expenses and Other Current Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	11.4	1.4
Not designated derivative assets, fair value	2.7	3.4
Foreign exchange forward contracts | Other Noncurrent Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	10.4	0
Not designated derivative assets, fair value	0	0
Foreign exchange forward contracts | Accrued Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	6.5	13.4
Not designated derivative liabilities, fair value	4.3	3.7
Foreign exchange forward contracts | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	1	4.5
Not designated derivative liabilities, fair value	0	0
Interest rate swaps
Derivative [Line Items]
Derivative liability, fair value, gross	0.3	0.4
Interest rate swaps | Prepaid Expenses and Other Current Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	0	0
Interest rate swaps | Other Noncurrent Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	0	0
Interest rate swaps | Accrued Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	0.3	0.3
Interest rate swaps | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	0	$ 0.1
Cross currency basis swaps
Derivative [Line Items]
Derivative asset, fair value, gross	3
Cross currency basis swaps | Prepaid Expenses and Other Current Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	0
Cross currency basis swaps | Other Noncurrent Assets, Net
Derivative [Line Items]
Derivative asset, fair value, gross	3
Cross currency basis swaps | Accrued Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	0
Cross currency basis swaps | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative liability, fair value, gross	$ 0

FINANCIAL INSTRUMENTS AND DER63

FINANCIAL INSTRUMENTS AND DERIVATIVES - BALANCE SHEET OFFSETTING (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Derivative Asset [Abstract]
Gross Amounts Recognized	$ 27.9	$ 4.8
Gross Amount Offset on the Consolidated Balance Sheets	0	0
Net Amounts Presented on the Consolidated Balance Sheets	27.9	4.8
Gross amounts not offset on the balance sheets, financial instruments	(12.2)	(3.9)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0	0
Net Amount	15.7	0.9
Derivative Liability [Abstract]
Gross Amounts Recognized	12.5	22
Gross Amount Offset on the Consolidated Balance Sheets	0	0
Net Amounts Presented on the Consolidated Balance Sheets	12.5	22
Gross amounts not offset on the balance sheets, financial instruments	(12.2)	(3.9)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0	0
Net Amount	0.3	18.1
Foreign exchange forward contracts
Derivative Asset [Abstract]
Gross Amounts Recognized	24.9	4.8
Gross Amount Offset on the Consolidated Balance Sheets	0	0
Net Amounts Presented on the Consolidated Balance Sheets	24.9	4.8
Gross amounts not offset on the balance sheets, financial instruments	(9.5)	(3.9)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0	0
Net Amount	15.4	0.9
Derivative Liability [Abstract]
Gross Amounts Recognized	12.2	21.6
Gross Amount Offset on the Consolidated Balance Sheets	0	0
Net Amounts Presented on the Consolidated Balance Sheets	12.2	21.6
Gross amounts not offset on the balance sheets, financial instruments	(12)	(3.8)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0	0
Net Amount	0.2	17.8
Interest rate swaps
Derivative Liability [Abstract]
Gross Amounts Recognized	0.3	0.4
Gross Amount Offset on the Consolidated Balance Sheets	0	0
Net Amounts Presented on the Consolidated Balance Sheets	0.3	0.4
Gross amounts not offset on the balance sheets, financial instruments	(0.2)	(0.1)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0	0
Net Amount	0.1	$ 0.3
Cross currency basis swaps
Derivative Asset [Abstract]
Gross Amounts Recognized	3
Gross Amount Offset on the Consolidated Balance Sheets	0
Net Amounts Presented on the Consolidated Balance Sheets	3
Gross amounts not offset on the balance sheets, financial instruments	(2.7)
Gross amounts not offset on the balance sheets, cash collateral received/pledged	0
Net Amount	$ 0.3

FAIR VALUE MEASUREMENT - ADDITI

FAIR VALUE MEASUREMENT - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Estimate of Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	$ 1,598.5	$ 1,629.9
Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	$ 1,595.4	$ 1,620.8

FAIR VALUE MEASUREMENT - FINANC

FAIR VALUE MEASUREMENT - FINANCIAL ASSETS AND LIABILITIES THAT ARE RECORDED AT FAIR VALUE AND CLASSIFIED BASED ON THE LOWEST LEVEL OF INPUT (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	$ 27.5	$ 59.2
Liabilities	20.9	30.6
Cross currency basis swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	3
Foreign exchange forward contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	24.5	4.8
Liabilities	11.8	21.6
Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0.3	0.4
Contingent considerations on acquisitions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	8.8	8.6
Available-for-sale security
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		54.4
Fair Value, Inputs, Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Fair Value, Inputs, Level 1 | Cross currency basis swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Fair Value, Inputs, Level 1 | Foreign exchange forward contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Fair Value, Inputs, Level 1 | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Fair Value, Inputs, Level 1 | Contingent considerations on acquisitions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Fair Value, Inputs, Level 1 | Available-for-sale security
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		0
Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	27.5	59.2
Liabilities	12.1	22
Fair Value, Inputs, Level 2 | Cross currency basis swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	3
Fair Value, Inputs, Level 2 | Foreign exchange forward contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	24.5	4.8
Liabilities	11.8	21.6
Fair Value, Inputs, Level 2 | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0.3	0.4
Fair Value, Inputs, Level 2 | Contingent considerations on acquisitions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Fair Value, Inputs, Level 2 | Available-for-sale security
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		54.4
Fair Value, Inputs, Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	8.8	8.6
Fair Value, Inputs, Level 3 | Cross currency basis swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Fair Value, Inputs, Level 3 | Foreign exchange forward contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Fair Value, Inputs, Level 3 | Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Fair Value, Inputs, Level 3 | Contingent considerations on acquisitions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 8.8	8.6
Fair Value, Inputs, Level 3 | Available-for-sale security
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		$ 0

FAIR VALUE MEASUREMENT - LEVEL

FAIR VALUE MEASUREMENT - LEVEL 3 LIABILITIES WITH UNOBSERVABLE INPUTS (Details) $ in Millions	6 Months Ended
	Jun. 30, 2018USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at December 31, 2017	$ 8.6
Reported in Other expense (income), net	0.4
Effect of exchange rate changes	(0.2)
Balance at June 30, 2018	$ 8.8

INCOME TAXES - ADDITIONAL INFOR

INCOME TAXES - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Excess tax benefit recorded during period	$ 0.5	$ 4.2
Tax expense from release of valuation allowance	0.7
Tax expense related to enacted statutory rate changes	2.5	0.5
Tax benefit for other discrete tax matters	(0.6)	1.5
Indefinite-lived intangible asset impairment charges	50.4	$ 23.5
Fixed asset impairment charges	1.1
Tax deductible goodwill	3.3
Tax expense related to gain on sale of marketable securities	0.6
Tax expense related to transition tax for accumulated foreign earnings, provisional liability	$ 1

FINANCING ARRANGEMENTS (Details

FINANCING ARRANGEMENTS (Details) - USD ($)	3 Months Ended
	Jun. 30, 2018	Jul. 27, 2018
Line of Credit Facility [Line Items]
Proceeds from issuance of commercial paper	$ 205,000,000
Line of Credit | Line of Credit
Line of Credit Facility [Line Items]
Borrowings available under lines of credit	322,900,000
Line of Credit | Revolving Credit Facility
Line of Credit Facility [Line Items]
Outstanding borrowings	0
Maximum borrowing capacity	$ 500,000,000
Line of Credit | Revolving Credit Facility | Subsequent Event
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 700,000,000

GOODWILL AND INTANGIBLE ASSET69

GOODWILL AND INTANGIBLE ASSETS - RECONCILIATION OF CHANGES IN GOODWILL (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018	Dec. 31, 2017
Goodwill [Roll Forward]
Balance, beginning of the year	$ 4,539.2
Acquisition related additions	66.5
Measurement period adjustments on prior acquisitions	0.5
Goodwill impairment	(1,085.7)
Effects of exchange rate changes	(62.7)
Balance, end of the year	3,457.8
Goodwill, Impaired, Accumulated Impairment Loss [Abstract]
Gross Carrying Amount		$ 6,194.4	$ 6,190.1
Cumulative Impairment		(2,736.6)	(1,650.9)
Net Carrying Amount	4,539.2	3,457.8	4,539.2
Technologies & Equipment
Goodwill [Roll Forward]
Balance, beginning of the year	3,660.6
Acquisition related additions	0
Measurement period adjustments on prior acquisitions	0
Goodwill impairment	(1,017.2)
Effects of exchange rate changes	(51.3)
Balance, end of the year	2,592.1
Goodwill, Impaired, Accumulated Impairment Loss [Abstract]
Gross Carrying Amount		5,260.2	5,311.5
Cumulative Impairment		(2,668.1)	(1,650.9)
Net Carrying Amount	3,660.6	2,592.1	3,660.6
Consumables
Goodwill [Roll Forward]
Balance, beginning of the year	878.6
Acquisition related additions	66.5
Measurement period adjustments on prior acquisitions	0.5
Goodwill impairment	(68.5)
Effects of exchange rate changes	(11.4)
Balance, end of the year	865.7
Goodwill, Impaired, Accumulated Impairment Loss [Abstract]
Gross Carrying Amount		934.2	878.6
Cumulative Impairment		(68.5)	0
Net Carrying Amount	$ 878.6	$ 865.7	$ 878.6

GOODWILL AND INTANGIBLE ASSET70

GOODWILL AND INTANGIBLE ASSETS - IDENTIFIABLE DEFINITE-LIVED AND INDEFINITE-LIVED INTANGIBLE ASSETS (Details) - USD ($) $ in Millions	Jun. 30, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,633.6	$ 2,602.2
Accumulated Amortization	(742.2)	(648.3)
Net Carrying Amount	1,891.4	1,953.9
Identifiable intangible assets, gross	3,289	3,449
Identifiable intangible assets, net	2,546.8	2,800.7
Trade names and trademarks
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, gross carrying amount	655.4	846.8
Patents and developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,416.1	1,385.5
Accumulated Amortization	(353.5)	(305)
Net Carrying Amount	1,062.6	1,080.5
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	82.6	76.4
Accumulated Amortization	(61.5)	(46.5)
Net Carrying Amount	21.1	29.9
Licensing agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	36.1	31.2
Accumulated Amortization	(25.4)	(24.8)
Net Carrying Amount	10.7	6.4
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,098.8	1,109.1
Accumulated Amortization	(301.8)	(272)
Net Carrying Amount	$ 797	$ 837.1

GOODWILL AND INTANGIBLE ASSET71

GOODWILL AND INTANGIBLE ASSETS - NARRATIVE (Details) $ in Millions	Apr. 30, 2018USD ($)segment	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2017USD ($)	Dec. 31, 2017USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of reporting units | segment	11
Goodwill		$ 3,457.8		$ 3,457.8		$ 4,539.2
Goodwill impairment		1,085.8	$ 1,092.9	1,085.8	$ 1,092.9
Indefinite-lived intangible asset impairment	$ 179.2		$ 79.8	179.2	$ 79.8
Treatment Centers
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Sensitivity analysis, reduction rate	10.00%
Goodwill		$ 292.7		$ 292.7
Discounted Cash Flow | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Goodwill measurement period	5 years
Goodwill forecasted cash flows, discount rate	7.90%
Discounted Cash Flow | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Goodwill measurement period	10 years
Goodwill forecasted cash flows, discount rate	10.50%

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	Nov. 08, 2017USD ($)
Arbitration With Roth Licensing
Loss Contingencies [Line Items]
Litigation settlement amount	$ 16